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The widespread conversion of drunk drivers to drugged drivers means that forensic 
laboratories have had to drastically increase the scope of their DUI/DUID testing.  This increased 
scope has caused an expansion of the types of laboratory instrumentation used.  In an attempt to 
identify the instrument best suited for DUI/DUID casework, an in-depth analysis was performed 
that evaluated presently-applied techniques as well as emerging techniques.  This was followed 
by an analysis of the analytical efficiency of each instrument, see Table 1 below. 
Table 1. 
 
This study showed that there is not a one-size-fits-all preferred instrument for the analysis 
of DUI/DUID case samples.  The variations in laboratory needs, capabilities, and definitions of 
analytical efficiency are why there is not a single best instrument.  Instead, there are several 
instruments available that complement one another in the analysis of DUI/DUID case samples 
when used in conjunction with each other.  While some of the emerging techniques appear to be 
more analytically efficient than presently-applied techniques, this does not discount the overall 
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 In August of 1997, the world was shocked by the sudden death of Diana, Princess of 
Wales.  While there were many conspiracy theories surrounding the cause of her death, 
eventually, the automobile accident that claimed her life was determined to have been caused by 
her driver having been “driving under the influence”.  Henri Paul, the Ritz Security Officer and 
the driver of the vehicle, was found to have had both alcohol (three times the French legal limit) 
and drugs (antidepressants and antipsychotics) in his system.  The alcohol is believed to have 
enhanced the effects of the antidepressants and antipsychotics in his system, thus increasing the 
effect of the impairment caused by the alcohol alone.  (Stevens, 2006). 
 According to the U.S. Centers for Disease Control and Prevention, about one third of 
U.S. fatal car accidents are caused by alcohol-impaired driving, nearly 11,000 deaths annually 
(Bergen, Shults, & Rudd, 2011).  According to the U.S. Substance Abuse and Mental Health 
Services Administration (SAMHSA), in 2014 the U.S. suffered approximately one fatality every 
53 minutes that was caused by alcohol-impaired driving.  SAMHSA also reported that in 2014 
11.1% of drivers aged 16 or older drove under the influence of alcohol, and 4.1% of drivers aged 
16 or older drove under the influence of illicit drugs.  (Lipari, Hughes, & Bose, 2016).  The U.S. 
Governors Highway Safety Association (GHSA) observed a slight decrease in alcohol-impaired 
driving fatalities, and a noticeable increase in drug-impaired driving fatalities from 2006-2016.  
In 2015 and 2016, the GHSA observed that more impaired-driving fatalities were caused by 
drugs than by alcohol.  The GHSA has also observed that increasingly, impaired-drivers are 
under the influence of some combination of drugs and alcohol. (Hedlund, 2018).  The U.S. 
National Highway Traffic Safety Administration (NHTSA) noted a 3.6% decrease in alcohol-
impaired driving fatalities from 2017 to 2018, where alcohol-impairment was defined as a blood 
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alcohol concentration over 0.08 g/dL.  In 2018, alcohol-impaired driving accounted for 29% of 
the total fatal motor vehicle crashes.  Unfortunately, the NHTSA failed to identify or quantify 
any motor vehicle fatalities that may have been caused by drug-impaired driving.  (National 
Highway Traffic Safety Administration, 2019). 
 These statistics cause one to wonder what DUI really means.  Driving under the influence 
(DUI) is illegal in all 50 U.S. states.  Originally, DUI’s were associated exclusively with drunk 
driving, however as drug use and abuse issues accelerate, drugged driving has also come to be 
associated with the term DUI.  States have now begun to differentiate between drunk driving and 
drugged driving by charging drugged drivers with the offense of driving under the influence of 
drugs (DUID).  (National Institute on Drug Abuse, National Institutes of Health, & U.S. 
Department of Health and Human Services, 2019; Hedlund, 2018). 
So, what is the difference between drunk driving and drugged driving?  Drunk driving is 
driving under the influence of alcohol.  49 U.S. states consider a driver over the age of 21 to be 
alcohol-impaired if their blood alcohol content (BAC) is over 0.08 g/dL; Utah is the outlier, as it 
recently lowered its legal limit to 0.05 g/dL.  Some states have a form of zero-tolerance law for 
alcohol-impaired driving under the age of 21, while many states have a limit of 0.02 g/dL for 
underage drivers.  (Nolo, n.d.).  Drugged driving is driving under the influence of drugs, with 
marijuana and opioids being the most prevalent.  Drugged driving is particularly dangerous 
because impairment can be caused by both prescription and illicit drugs.  A key issue with 
determining drugged driving is that the concentration of drug(s) required to cause impairment is 
not well understood; there is not a direct relationship between drug concentration and 
impairment.  Individual drugs, combinations of multiple drugs, or drugs and alcohol together 
cause different effects of impairment, none of which are well understood.  However, it is 
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generally accepted that alcohol in combination with drugs acts synergistically to increase 
impairment.  Thus, there are no uniform concentrations levels used for the identification of a 
drug-impaired driver.  Instead, many states have zero-tolerance drugged driving laws, where 
drivers found driving with any detectable drug, prescribed and/or illicit, are considered impaired, 
irrespective of actual impairment.  Alternatively, some states have set “per se” limits on specific 
drugs, prescribed and/or illicit, which means that if a driver is found with drug concentrations 
above a certain limit, they are considered impaired, again, irrespective of actual impairment.  
Since the presence of drugs does not necessary imply impairment, many states are waiting for 
conclusive research over drug concentration and level of impairment prior to the development of 
“per se” laws.  Reaching conclusive consensus is challenging; for example, in regard to THC 
concentrations, there are many conflicting studies correlating blood concentration and level of 
impairment.  (National Institute on Drug Abuse, National Institutes of Health, & U.S. 
Department of Health and Human Services, 2019; Hedlund, 2018; Compton & Berning, 2015; 
Armentano, 2013). 
Statement of the Problem 
The widespread conversion of drunk drivers to drugged drivers means that forensic 
laboratories have had to drastically increase the scope of their DUI/DUID testing.  This increased 
scope has caused an expansion of the types of laboratory instrumentation used. 
Daubert is the legal precedent used to determine the admissibility of analytically-derived 
evidence; its five prongs are: validation, controlled conditions (repeatability), peer review, 
erroneous results, and general acceptance in the relevant scientific community.  (Koon, 1994).  
Before an analytical instrument can be used for casework, it must be evaluated by all of the 
Daubert prongs.  Methods are typically peer reviewed and generally accepted by the relevant 
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scientific community prior to the purchase of an analytical instrument.  Upon installation, the 
method must undergo extensive validation, which is performed under controlled conditions, 
theoretically minimizing the potential for erroneous results. 
This literature review evaluates presently-applied techniques which have already 
undergone peer review and are generally accepted in the forensic science community, and 
evaluates emerging techniques that are still undergoing the process of peer review and general 
acceptance in the forensic science community.  The methods validated, the conditions used for 
testing, and the potential for erroneous results have been reviewed.  This review includes an 
analysis of each instrument against a set of evaluation parameters, the definition of analytical 
efficiency, and the author’s conclusions regarding which instrument provides the best analytical 
efficiency for DUI/DUID casework. 
Background 
 Drunk driving has been a problem for more than 100 years, with the first recorded drunk 
driving incident occurring in London, England in 1897.  A taxi driver named George Smith 
crashed his cab into a building, and upon pleading guilty, was fined 25 shillings.  In 1906, New 
Jersey became the first state to enact a drunk driving law, followed by New York in 1910.  
Because these early laws were not based on a quantitative definition of alcohol-impairment, 
outward signs of intoxication were used to identify alcohol-impairment.  The first 
instrumentation used to identify alcohol-impairment was the Drunkometer in 1936, followed by 
the Breathalyzer in 1953.  The Breathalyzer was determined to be more manageable and more 
accurate than the Drunkometer, which is why variations of it are still in use.  (History.com, 2009; 
Birchfield v. North Dakota, 2016). 
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 Today, breathalyzers are still used for roadside testing of impaired drivers.  Roadside 
tests include: breathalyzers, field sobriety tests, and the use of drug recognition experts 
(Hedlund, 2018).  While roadside tests are outside the scope of the literature review, they are 
important because they provide the probable cause necessary for the collection of a biological 
sample, and the subsequent evidentiary DUI/DUID tests performed on that sample, all of which 
are the focus of the literature review. 
Purpose of Study 
 The purpose of this literature review is to evaluate the various types of presently-applied 
and emerging laboratory instrumentation most commonly available for use in the identification 
of drugs and alcohol in impaired driving cases.  This analysis involves the evaluation of these 
instruments against a specific set of parameters covering: instrument set-up, sample preparation, 
instrument results, and data analysis.  Margin of error and cost will also be discussed, but in a 
more general sense, because information covering these topics is not readily available in the 
published literature.  This literature review has attempted to identify the forensic laboratory 
instrumentation with the highest analytical efficiency for DUI/DUID casework.  This analysis 
includes: a description of current forensic laboratory DUI/DUID workflow; a description of the 
substrates used for DUI/DUID cases; and, a description of target drugs/drug classes that are 
commonly identified in DUI/DUID samples.  Because analytical efficiency has a subjective 
definition, this literature review also includes a review of the topic of analytical efficiency, and 
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Scope of Study 
The scope of this literature review was limited by the following four factors: 
1. It did not involve a bench study comparing the different types of instrumentation that can 
be used for DUI/DUID cases.  This research was a literature review that evaluated the 
different types of instrumentation on a theoretical basis.  Interested parties may choose to 
transition some of these theoretical instrumental approaches to validation studies. 
2. The drugs/drug classes involved in this evaluation were limited to those most commonly 
encountered in DUI/DUID cases; all are Tier I compounds as described by the National 
Safety Council’s Alcohol, Drugs and Impairment Division (Logan, et al., 2017). 
3. It did not include an evaluation of roadside tests, such as breathalyzers, field sobriety 
tests, or the use of drug recognition experts, though the results of these roadside tests are 
taken into consideration when performing DUI/DUID laboratory analyses.  Instead, this 
study focused on the instrumental approaches used by forensic laboratories to perform 
evidentiary DUI/DUID tests on biological samples. 
4. The instrumental approaches were evaluated against a specific set of parameters; 
however, these parameters are not all-inclusive.  They were limited by the information 
that is available in published literature. 
Significance to the Field 
This study should assist forensic laboratories in identifying the laboratory instrumentation 
with the highest analytical efficiency for their specific DUI/DUID casework.  The goal of 
forensic laboratories should be to produce accurate and reliable results as efficiently as possible.  
Ideally, this literature review will aid forensic laboratories in making purchasing decisions for 
new instrumentation, and help them learn how to better utilize their existing instrumentation. 
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 Even though the focus of this literature review is DUI/DUID casework, this analysis of 
laboratory instrumentation can also be applicable to other forensic toxicology subsets, such as 
drug-assisted sexual assault and post-mortem drug analysis.  Additional research may be 
required for these applications, as they often employ the use of matrices that are outside the 
scope of this literature review. 
This study’s theoretical descriptions of the presently-applied and emerging techniques 
used in forensic science laboratories, may also be used to aid the comprehension and 
understanding of court officials, lawyers, and law enforcement officers.  This is significant, 
because it may help contribute to the general acceptance of these techniques in a court of law. 
Methods 
The research methodology used for this analysis included: a review of published 
literature, a review of textbooks, a review of the websites of instrument manufacturers, attempts 
to contact instrument manufacturers for more specific information, and interviews of relevant 
individuals.  This literature review was followed by an evaluation of the data gathered against the 
previously-described evaluation parameters, followed by an analysis of the analytical efficiency 
of the presently-applied and emerging DUI/DUID analysis techniques. 
The review of published literature included searches in the University of Central 
Oklahoma Max Chambers Library, using the “Central Search” function, as well as searches in 
the Science Direct database accessed through the library.  Several articles were also requested 
and received through the Chambers Library Interlibrary Loan.  This review also included general 
Internet searches using the Google search engine to identify additional resources that might be 
relevant.  Internet searches facilitated the identification of regulatory guidance related to forensic 
science analyses, and patents related to the instrumentation being reviewed. 
Analysis of Forensic Laboratory Instrumentation Used for DUI/DUID Cases 
Pg. 9 
 
The review of textbooks included those owned by the author that were obtained in both 
undergraduate and graduate studies.  The review also included textbooks that were available 
online through University of Central Oklahoma Max Chambers Library.  Several textbooks 
pertaining to forensic science, chromatography, toxicology, pharmacology, and measurement 
uncertainty were identified and used. 
The instrument manufacturer websites that were reviewed included: Thermo Fisher 
Scientific, Agilent Technologies, Sciex, Waters Corporation, Perkin Elmer, and Shimadzu 
Corporation.  These instrument manufacturers were selected based on the American Chemical 
Society’s (ACS) Top Instrument Firms of 2018 ranking.  The ACS ranked the top 20 instrument 
manufacturers worldwide based on 2018 instrument sales.  This list included eight American 
companies; the websites for these companies were reviewed, and the five most relevant 
companies were selected: Thermo Fisher Scientific, Agilent Technologies, Danaher (the 
company that owns Sciex), Waters Corporation, and PerkinElmer.  Shimadzu was a later 
addition to the instrument manufacturers reviewed, but it was also in the ACS top 20 ranking.  
(Reisch, 2019). 
The purpose of the website reviews was twofold: identify the relevant instruments offered 
by the selected instrument manufacturers, and identify the resources manufacturers have 
available on their websites to aid in method development.  This information was then put into a 
table to compare instrument manufacturers against one another for the specific instruments 
reviewed.  The results of this analysis are in Appendix A – Instrument Manufacturer Analysis. 
Because the information available in published literature and on instrument manufacturer 
websites does not include objective information related to cost, instrument sensitivity, time 
required for instrument set-up, instrument maintenance, and other various criteria, an attempt 
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was made to contact instrument manufacturers for more specifics on those criteria.  The selected 
manufacturers were sent a cover letter explaining the purpose of the research, as well as a 
questionnaire to fill out (see Appendices B and C).  These cover letters and questionnaires were 
sent to the customer service e-mail addresses on the instrument manufacturer websites for 
Agilent Technologies, Sciex, and Waters Corporation.  Thermo Fisher Scientific and 
PerkinElmer did not list customer service e-mails, so the cover letter was sent through the 
“Contact Us” page of these websites.  A copy of this cover letter and questionnaire were also 
sent to a sales representative at Shimadzu, who is a “friend of a friend”, and later to an 
applications support scientist at Sciex who is a contemporary of the author.  Because the survey 
did not involve the identification of particular individuals, or persons from 
disadvantaged/marginalized groups, Institutional Review Board approval was not required.  
(Appendix B – Instrument Manufacturer Cover Letter; Appendix C – Instrument Manufacturer 
Questionnaire). 
Individuals interviewed for this review included the Technical Manager of the 
Toxicology Unit of the Oklahoma State Bureau of Investigation (OSBI), and two representatives 
from Sciex.  The OSBI analyst was contacted in order for the author to gain a better 
understanding of the workflow of forensic laboratories, as well as examples of presently-applied 
and emerging analytical techniques that were recommended for review.  The Sciex 
representatives were interviewed in relation to the instrument manufacturer survey they received; 








Brief History of Toxicological Techniques 
 The study and practice of toxicology date back to pre-historic humans, and their use of 
plant poisons and animal venoms for hunting and war.  The use of analytical techniques to 
identify poisons in human remains dates back to the nineteenth century, while the use of 
analytical instrumentation for drug analysis only dates back to the mid-twentieth century.  The 
use of analytical instrumentation for drug analysis has included: the use of thin layer 
chromatography, starting in the 1950s; the use of ultraviolet spectrophotometry, starting in the 
1950s and 1960s; the use of immunoassays, starting with radioimmunoassay (RIA) in the 1950s 
and 1960s; the introduction of enzyme-linked immunosorbent assay (ELISA) and enzyme-
multiplied immunoassay technique (EMIT) in the 1970s, and a whole succession of various 
immunoassay techniques since then; the use of capillary electrophoresis, starting in the 1960s; 
the use of REMEDi-HPLC, popular in the 1990s and early 2000s; and finally, the classic 
mainstays of gas-liquid chromatography (GLC), high performance liquid chromatography 
(HPLC), and hyphenated techniques utilizing mass spectrometry.  While much of this 
instrumentation is outside the scope of the literature review, it is important to recognize how 
relatively new instrumental analytical techniques are, and to appreciate the development and 
refinement of these techniques in such a short period of time.  (Klaassen, 2008; Langman & 
Kapur, 2006; Monroe, 1984). 
 Chromatography is the current cornerstone of toxicology and drug analysis, because it 
involves the separation of mixtures.  It is a differential migration process that is used to separate 
mixtures of matrices/endogenous substances and drugs, mixtures of drugs and metabolites, and 
mixtures of multiple drugs and/or metabolites.  The discovery of chromatography is typically 
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credited to Mikhail Semyonovich Tswett, a Russian chemist, who in 1903 separated leaf 
pigments using a chalk column.  Tswett named this technique chromatography, or color writing, 
using the Greek words “croma” (color) and “grafeih” (writing).  Since that time, there have been 
several different types of chromatography developed, which include: solid state gas 
chromatography, also known as gas-solid chromatography, in 1941; liquid-liquid 
chromatography (which became HPLC), in 1941; paper chromatography, in 1944; and gas-liquid 
chromatography (most commonly referred to as gas chromatography), also in the 1940s.  
(Langman & Kapur, 2006). 
 Mass spectrometry is considered by many to be the gold standard for toxicological drug 
confirmation.  It is a strong-held belief in forensic science, that unless there is a spectral match, a 
drug has not been properly confirmed.  The development of mass spectrometry is credited to 
Cambridge University professor Sir Joseph John Thompson, who in 1907 developed a device to 
positively charge ions, which were then forced through a magnetic field, then struck a screen and 
created unique patterns.  It was noted at the time, that pure compounds always created the same 
pattern, and could be easily identified, but mixtures proved to be problematic.  (Houck & Siegel, 
2011; Jones, 2019). 
Current Forensic Laboratory DUI/DUID Workflow 
While the methods used to process DUI/DUID cases are lab specific, they generally 
include both presumptive and confirmatory testing of DUI/DUID samples.  Presumptive tests, 
also referred to as preliminary tests, are used to screen samples for the presence of common 
drugs/drug classes.  Presumptive tests are typically in the form of immunoassays; however, they 
can also include chromatographic methods.  Major advantages of presumptive tests are that most 
of them require little or no sample prep, and can produce results fairly quickly.  Presumptive 
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tests are used to direct the path of confirmation tests; this is important because different 
drugs/drug classes may require different extraction techniques, or the use of different types of 
instrumentation.  Confirmation tests typically use chromatography, coupled with mass 
spectrometry, to confirm the specific drug(s) in a sample.  Confirmation tests are different from 
presumptive tests, because presumptive tests may only be able to identify a drug class, whereas 
confirmation tests will be able to identify the specific drug(s) in the indicated drug class(s).  
Though differences may be subtle, every compound has a unique splitting pattern; this allows for 
spectral matches to conclusively identify individual drug(s), and as such, spectral confirmation is 
the industry standard for drug confirmation.  Different methods, such as derivatization, can be 
employed to help differentiate among the subtleties of splitting patterns.  (Houck & Siegel, 2011; 
Anderson, 2005; Jones, 2019; Lin, et.al., 2008). 
Since impaired driving events have been traditionally caused by alcohol-impairment, 
alcohol is typically the first drug for which DUI/DUID samples are evaluated.  In the Oklahoma 
State Bureau of Investigation (OSBI) Forensic Science Center in Edmond, if alcohol is identified 
and quantified above the legal limit, no other tests are performed.  If alcohol is not identified, or 
is not quantified above the legal limit, then further testing is performed.  This testing includes 
screening by ELISA, and confirmation of any presumptive positives, as well as a review of the 
drug recognition expert’s (DRE) analysis for drugs/drug classes that cannot be screened for by 
ELISA, followed by confirmation testing for these substances.  Since Oklahoma is a zero-
tolerance drug state, as soon as a drug (therapeutic or illicit) is identified, no other tests are 
performed.  States with “per se” limits on drugs may additionally require quantitation of 
confirmed drugs.  This process can be limited by the quantity of biological sample received by 
the laboratory, which can dramatically vary in size.  Presumptive testing is important, because it 
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directs the consumption of the sample down the most efficient path, toward the assays most 
likely to produce the required results.  (Ross-Carr, 4/20/20). 
Sample Matrices and Extraction Methods 
There are a number of matrices that can be evaluated to determine drug use.  Some, like 
blood and oral fluid, give the live concentration of an analyte.  Others, such as urine and hair, are 
able to indicate historical drug use, but do not provide information on the drugs affecting an 
individual at the time of sample collection.  This section will review whole blood and oral fluid 
as matrices that can be used for the analysis of DUI/DUID cases, as well as the common sample 
preparation methods used for these matrices.  These matrices were chosen based on the results of 
the toxicology survey that was part of the National Safety Council’s Alcohol, Drugs and 
Impairment Division’s Recommendations for Toxicological Investigation of Drug-Impaired 
Driving and Motor Vehicle Fatalities – 2017 Update.  (Logan, et.al., 2017).  Of the laboratories 
surveyed, 90% reported that they test whole blood samples for DUI/DUID cases, 68% reported 
that they test urine samples for DUI/DUID cases, and 1% reported that they test oral fluid for 
DUI/DUID cases.  Since the report also referenced a 2013 recommendation discouraging the use 
of urine as a specimen for DUI/DUID cases, because urine results provide historical data rather 
than the live concentration, urine will not be discussed.  Because whole blood is the matrix most 
commonly analyzed in DUI/DUID cases, it will be the focus of the remainder of the literature 
review. 
Whole Blood 
 Whole blood (referred to simply as blood going forward) is the matrix most commonly 
collected for analysis in DUI/DUID cases, because blood provides the live concentration of 
drugs at the time of sample collection.  The presence of free, unbound drugs in blood indicates 
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recent use; because unbound drugs are pharmacologically active, they are a likely cause of 
impairment.  Protein-bound drugs are not typically pharmacologically active, thus not the cause 
of impairment; this is why most DUI/DUID detection methods do not include a hydrolysis step 
to free protein-bound drugs.  (Langman & Kapur, 2006; Raes, Verstraete, & Wennig, 2008). 
 Broadly speaking, blood is composed of two components: plasma and blood cells.  The 
composition of plasma includes: proteins (including antibodies, transport molecules, and 
enzymes), minerals, and aqueous glucose.  Plasma is the fraction of blood in which most drugs 
concentrate; however, some drugs also concentrate in red blood cells, the primary component of 
the blood cell fraction.  The unequal distribution of drugs between blood fractions is why whole 
blood is a more appropriate matrix than plasma for DUI/DUID testing.  (Koen & Bowers, 2017; 
Langman & Kapur, 2006). 
The unequal distribution of drugs between blood fractions, in combination with the 
varying chemical properties of different drugs, is why there is not a one-size-fits-all preferred 
extraction process for DUI/DUID testing.  (The chemical properties of specific drugs/drug 
classes will be discussed in more detail later, with the description of the drugs/drug classes.)  The 
most common extraction techniques used for blood samples include: liquid-liquid extraction, 
solid-phase extraction, and protein precipitation.  It is important to note that the type of 
extraction technique used can affect the quality of the chromatographic separation and 
subsequent detection of target analytes.  (Leung & Fong, 2014; Jemal, 2000). 
Liquid-Liquid Extraction 
Liquid-liquid extractions (LLE) involve the partitioning of target analytes from an 
aqueous matrix into an organic solvent which is then evaporated.  Evaporation is followed by a 
reconstitution step, which concentrates the extracted analytes.  Generally, drugs fall into three 
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classes, basic, neutral, and acidic, with a majority of relevant drugs being basic or neutral.  
Because of the varying chemical properties of the drugs involved, LLE are often broken down 
into two types, basic extraction and acidic extraction, with neutral drugs being extracted by both 
methods.  Basic extractions involve the basification of the matrix with a buffer, and the 
subsequent application of an extraction solvent.  Acidic extractions involve the acidification of 
the matrix with a buffer, and the subsequent application of an extraction solvent.  Extraction 
solvents need to be optimized in order to fully extract target analytes, while also 
preventing/minimizing the coextraction of interfering endogenous substances.  LLE can be 
automated, and when performed properly, can give very clean extracts.  (Kostakis Harpas, & 
Stockham, 2013; Leung & Fong, 2014; Jemal, 2000; Thermo Fisher Scientific, n.d.). 
Solid-Phase Extraction 
Solid-phase extractions (SPE) involve the use of a sorbent, typically in a cartridge or a 
96-well plate, that has an affinity for the target analytes in the matrix.  The matrix is passed 
through the sorbent, and the sorbent retains the target analytes by non-bonding interactions.  An 
elution solvent, with a higher affinity for the target analytes than the sorbent, is then applied to 
the sorbent, thus releasing the target analytes.  This solvent may then be injected into the 
chromatographic column, or evaporated and reconstituted to concentrate the target analytes prior 
to analysis.  There are many different sorbents that may be used for SPE; they have varying 
separation mechanisms, and may be used with a variety of elution solvents.  Some sorbents may 
include ion-exchange moieties, which allow for the separate elution of basic and acidic target 
analytes.  SPE can be automated, and when performed properly, can give clean extracts.  
(Kostakis Harpas, & Stockham, 2013; Leung & Fong, 2014; Jemal, 2000; Thermo Fisher 
Scientific, n.d.). 




Solid-Phase Micro-Extraction (SPME) is an extraction technique that has been gaining 
popularity for volatile and thermally-stable drugs; it is hailed as a “green” technique, because it 
is a solventless extraction.  Similar to SPE, the matrix is passed through a fiber-containing 
cartridge and the target analytes are adsorbed onto the fiber.  Unlike with SPE, the target analytes 
are not eluted from the fiber using an elution solvent; instead, the fiber is placed in the injector 
port of a gas chromatograph, and the target analytes are desorbed into the instrument.  This 
technique can also be used with headspace gas chromatography.  SPME offers much potential 
because: it uses small volumes of sample matrix; can be automated; and, by reducing sample 
manipulation, it reduces both the time required for sample preparation and the potential for 
analytical errors.  Also, this technique is known for producing clean extracts.  (Langman & 
Kapur, 2006; DeGiovanni & Fucci, 2008; Bogusz, 2008). 
Protein Precipitation 
Protein precipitation (PPT) is a simple clean-up procedure that is regarded for its speed 
and simplicity.  Its advantages are somewhat offset by the output of an extract with more 
endogenous contaminants, because the primary endogenous substances removed are the proteins.  
PPT is achieved by exploiting the solubility of proteins, and is most commonly performed by the 
application of an organic solvent with a small dielectric constant, or the application of a salt that 
outcompetes the protein for water.  PPT is considered to be universally applicable, because it can 
be used to extract almost any analyte, independent of chemical properties.  Because the extract 
produced often contains matrix contaminants, PPT is sometimes performed as a pretreatment 
step for LLE or SPE.  PPT can also be automated.  (Leung & Fong, 2014; Jemal, 2000; Thermo 
Fisher Scientific, n.d.). 




Depending upon the chromatography technique used, and the drugs being analyzed, 
samples may require chemical derivatization.  Derivatization is generally performed on samples 
that are going to be analyzed by gas chromatography mass spectrometry (GC/MS), though 
studies have been performed to determine if there are potential benefits in derivatizing samples 
for liquid chromatography mass spectrometry or tandem mass spectrometry (LC/MS and 
LC/MS/MS) analysis.  Chemical derivatization of analytes for LC/MS and LC/MS/MS is 
generally directed toward reactive carbonyl metabolites that exhibit chemical instability, such as 
acetoacetate and oxaloacetate, which, as endogenous compounds, are outside the scope of this 
study.  Of the articles analyzed for this literature review, almost all derivatized drugs in 
preparation for GC/MS analysis, but the derivatization of drugs in preparation for LC/MS/MS 
analysis was not mentioned.  Therefore, when discussing derivatization in this literature review, 
it will exclusively refer to GC/MS analysis.  (Lin, et.al., 2008; Lin, et.al., 2016). 
Typically, drugs are derivatized prior to GC/MS analysis for one or more reasons: 1) to 
improve analyte compatibility with the chromatographic environment; 2) to improve separation 
efficiency or achieve required analyte separation; or 3) to improve analyte detection and 
structural characterization.  Since GC/MS is not as compatible with analytes that are thermally 
instable, highly polar, or semi-/non-volatile, improving analyte compatibility is the primary 
reason chemical derivatization is performed.  Derivatization can improve analyte volatility, 
thermal stability, polarity, and recovery; it can also improve chromatographic properties, such as 
peak shape.  Derivatizing agents may create more ideal analytical conditions for separation 
efficiency by bringing the retention times of analytes into a more desirable range.  Achievement 
of required analyte separation may be used in the application of enantiomeric determination, 
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whereby enantiomers may be separated by the use of chiral derivatizing agents instead of, or in 
combination with, chiral stational phases.  Chemical derivatization can improve analyte 
detection, with the ability to lower the limit of detection for certain analytes when analyzed in 
negative chemical ionization mode versus positive chemical ionization mode.  Structural 
characterization can be improved by the production of better-defined mass spectra, thereby 
allowing for easier recognition of the molecular weight of analytes.  It is important to note that 
the use of columns with different stationary phases, or the use of temperature programing (versus 
isothermal operation), may change the derivatization requirements of certain analytes from 
mandatory to optional.  Though optional in some instances, derivatization may still be favored 
for the improvements it provides on GC/MS performance characteristics.  (Lin, et.al., 2008; Lin, 
et.al., 2016; Kabir & Furton, 2012). 
Derivatization can occur pre-column, as part of the sample preparation method, or on-
column as part of the instrumental analysis.  The most common derivatization reactions used for 
drug analysis are silylation, acylation, and alkylation.  The sites most commonly derivatized are 
labile protons on heteroatoms which contain the following functional groups: -COOH, -OH, -
NH, and -HN2; derivatization at carbon sites has also been reported.  Analyte-specific 
derivatization will be reviewed with the description of drugs/drug classes.  (Lin, et.al., 2008; Lin, 
et.al., 2016). 
Oral Fluid 
 Oral fluid is a matrix that is slowly gaining popularity as an alternative matrix for 
DUI/DUID cases; its primary advantage is that the collection process is non-invasive, compared 
to the invasive collection of blood.  Because of oral fluid’s increasing use and because oral fluid 
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can be tested on the same instrumentation used for blood samples, a short review of oral fluid has 
been included. 
Oral fluid, like blood, provides the live concentration of drugs at the time of sample 
collection, because it contains free drugs; it also has a tendency to contain parent drugs rather 
than metabolites.  Oral fluid has a detection window similar to that of blood, and drug 
concentrations in oral fluid have a good correlation with those found in blood.  Oral fluid is more 
than 97% water; it also contains electrolytes, immunoglobins, enzymes and some proteins.  This 
simple composition reduces the potential for interference caused by endogenous substances.  The 
extent of protein binding in oral fluid is minimal compared to blood, which forces drugs to 
convert into a water-soluble form to be retained in the oral fluid.  For most drugs, water-
solubility is attained via ionization, thus the concentration of drugs is dependent upon oral fluid 
pH.  The pH of oral fluid is normally in the range of 5.5-7.9; this wide range is a contrast to the 
fairly constant pH value of blood.  The pH of oral fluid can be affected by factors such as 
stimulation, flow rate, and smoking; interestingly, pH is not affected by alcohol consumption.  
Because oral fluid pH can be quite fluid, and analyte concentration can be dependent upon pH, 
collection devices typically include a collection buffer to stabilize pH, thus stabilizing analyte 
concentrations.  (DeGiovanni & Fucci, 2008; Rodrigues, et.al., 2013; Raes, Verstraete, & 
Wennig, 2008). 
 Oral fluid’s biggest downfall appears to be the variable influence of the collection 
method employed.  Studies comparing different collection devices have shown wide variability 
in drug concentrations between the different devices.  The reason for this variability is likely the 
collection buffers used, since each collection device uses a proprietary buffer; however, the 
variability can also be influenced by the method used to collect the sample, i.e. stimulated or not 
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stimulated collection.  This lack of uniformity of sample collection means that oral fluid methods 
are dependent on the specific collection device used; they do not usually have the ability to be 
applied to a wide variety of collection devices.  Additionally, until recently, there were not 
forensic guidelines for oral fluid cutoff concentrations.  The Recommendations for Toxicological 
Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities – 2017 Update referenced 
earlier provided some of the initial guidance on oral fluid testing in the context of DUI/DUID 
testing.  It should be noted that the cutoff concentrations used for oral fluid testing are generally 
lower than those used for whole blood analysis, because the concentration of drugs in oral fluid 
is lower than the concentration of drugs in whole blood.  (DeGiovanni & Fucci, 2008; Rodrigues, 
et.al., 2013; Raes, Verstraete, & Wennig, 2008; Langman & Kapur, 2006; Logan, et.al., 2017). 
Dilute-and-shoot 
There are several extraction methods that can be used with oral fluid samples, many of 
which are variations of those used for the extraction of blood; they include:  SPE, SPME, LLE, 
PPT, and dilute-and-shoot.  Because oral fluid has fewer endogenous components than blood, 
PPT produces a cleaner extract when extracting oral fluid samples than it does with blood.  
Dilute-and-shoot is a sample preparation method whereby the oral fluid sample is diluted by the 
extraction buffer, then an aliquot of the dilution is mixed with an internal standard (IS).  This 
mixture is centrifuged in some instances, but the centrifugation step is not performed in other 
instances.  The resulting dilution-IS solution is then injected into the instrument without any 
further sample processing.  Because oral fluid is a rather clean matrix to begin with, dilute-and-
shoot is a popular extraction technique.  (DeGiovanni & Fucci, 2008; Rodrigues, et.al., 2013; 
Raes, Verstraete, & Wennig, 2008). 
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Description of Drugs/Drug Classes 
The drugs/drug classes involved in this evaluation were limited to those most commonly 
encountered in DUI/DUID cases, and will be the focus of the remainder of the literature review.  
This approach was an effort to keep this literature review concise, relevant, and focused, as the 
number of potential drugs that could be encountered in DUI/DUID cases is seemingly limitless 
because of the growing number of novel, synthetic, and designer drugs.  All of the drugs/drug 
classes reviewed were Tier I compounds as described by the National Safety Council’s Alcohol, 
Drugs and Impairment Division, and were chosen by a review of the results of the toxicology 
survey that was part of the Recommendations for Toxicological Investigation of Drug-Impaired 
Driving and Motor Vehicle Fatalities – 2017 Update (Logan, et al., 2017). 
Alcohol 
 As discussed previously, early impaired-driving laws specifically applied to alcohol 
intoxication, and the early instrumentation that was used in DUI cases was alcohol specific.  In 
the United States, according to the Treasury Department, “The term alcohol means that 
substance known as ethyl alcohol [ethanol]”.  Alcohol is a central nervous system (CNS) 
depressant, specifically a sedative-hypnotic that depresses the CNS in a dose-dependent fashion.  
Alcohol is the only drug to have a known correlation between concentration and level of 
impairment.  Alcohol-impairment affects many behaviors that are necessary for driving including 
balance, coordination, reaction time, attention, decision-making, risk taking, and judgement.  
There are decades of research correlating increased accident risk with increased alcohol 
concentration; this research is the basis for the legal limits set by each state.  (Beale & Block, 
2011; Hedlund, 2018; Berning, Compton, & Wochinger, 2015). 
 




 Benzodiazepines are CNS depressants, specifically sedative-hypnotics; they cause 
sedation, hypnosis, blurred vision, confusion, slowed reflexes, slurred speech, and hypotension.  
Benzodiazepines have been used for the medical treatment of anxiety, insomnia, seizures, and 
pain management.  Benzodiazepines are also prone to illicit abuse.  Structurally, benzodiazepines 
can be divided into several categories: 1,4-benzodiazepines, nitro-benzodiazepines, imidazo-
benzodiazepines, triazolo-benzodiazepines, and miscellaneous benzodiazepines.  
Pharmacologically, benzodiazepines are divided into two categories low dose and high dose.  
1,4-Benzodiazepines are high-dose benzodiazepines that have oxazepam as a common 
metabolite; common 1,4-benzodiazepines include diazepam, nordiazepam, temazepam, and 
oxazepam.  Nitro-benzodiazepines are low-dose benzodiazepines that that commonly produce 7-
amino metabolites; common nitro-benzodiazepines include clonazepam and flunitrazepam.  
Imidazo-benzodiazepines are low-dose benzodiazepines that do not appear to have a common 
metabolite; midazolam is a common imidazo-benzodiazepine.  Triazolo-benzodiazepines are 
low-dose benzodiazepines that have alpha-hydroxy-alprazolam as a common metabolite; 
common triazolo-benzodiazepines include alprazolam and triazolam.  Benzodiazepines are 
alkaline in nature, so they are best extracted in basic conditions.  Benzodiazepines are thermally 
unstable and generally require derivatization by silylation or acylation for compatibility with 
GC/MS.  Derivatization improves the thermal stability of benzodiazepines, improves the 
chromatographic resolution, and produces better-defined mass spectra.  (Beale & Block, 2011; 
Logan, et al., 2017; Hutchings & Widdop, 2013; Bertol & Vaiano, 2016; Drummer, 1998; Corey, 
Czakó, & Kürti, 2007). 
 




 Amphetamines are CNS stimulants, specifically central sympathomimetic agents, also 
known as psychomotor stimulants; they cause elevated mood, increased alertness, self-
confidence, and concentration.  Their prolonged use can lead to weight loss, hallucinations, and 
paranoid psychosis.  Amphetamines have been used for the medical treatment of obesity, 
appetite suppression, attention-deficit disorders, narcolepsy, and Parkinson disease.  
Amphetamines are also prone to illicit abuse; designer amphetamines, such as 
methylenedioxyamphetamine (MDMA), do not have an accepted medicinal use.  Common 
amphetamines include amphetamine, methamphetamine, phentermine, and MDMA; 
amphetamine is their common metabolite.  Amphetamines are alkaline in nature, so they are best 
extracted in basic conditions.  In order to achieve the requisite chromatographic separation, and 
to generate better-defined mass spectra, derivatization by acylation is generally required for 
compatibility with GC/MS.  However, caution should be taken when using heptafluorobutyric 
anhydride or 4-carboxyhexaflurobutyl chloride, because there is evidence that high injection-port 
temperatures can cause the artificial conversion of derivatized ephedrine to methamphetamine 
when ephedrine is present in high concentrations.  (Beale & Block, 2011; Hutchings & Widdop, 
2013; Valentine & Middleton, 2000; Lin, et.al., 2008). 
Cocaine/Benzoylecgonine 
 Cocaine is a CNS stimulant, specifically a euphoriant-stimulant; it is also a local 
anesthetic.  Cocaine causes feelings of well-being, decreased fatigue, increased alertness, 
compulsion, vasoconstriction, increased blood pressure, increased heart rate, and increased body 
temperature; its prolonged use can lead to psychosis.  Cocaine has traditionally been used as a 
local anesthetic in surgery, but is more commonly abused illicitly.  Cocaine rapidly metabolizes 
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in the body and is more commonly identified by its primary metabolite, benzoylecgonine.  When 
cocaine and alcohol are taken simultaneously, the production of cocaethylene results, this 
metabolite is unique to the combination of cocaine and alcohol.  Benzoylecgonine and cocaine 
are alkaline in nature, so they are best extracted in basic conditions.  To improve 
chromatographic resolution, derivatization by acylation is generally required for compatibility 
with GC/MS.  (Beale & Block, 2011; Hutchings & Widdop, 2013; Lin, et.al., 2016) 
Opiates/Opioids 
 Opiates and opioids are narcotic analgesics; they cause analgesia, euphoria, narcosis, 
pinpoint pupils, and respiratory depression.  Opiates and opioids have been used for the medical 
treatment of acute pain, the management of chronic pain, and sometimes as antitussives.  Opiates 
and opioids are highly addictive, and are prone to illicit abuse.  Regular use of opiates and 
opioids leads to tolerance, which is why in 2017 a U.S. national public health emergency was 
declared in regard to the opioid crisis.  Opiates are drugs that are found in the unripe seed pod of 
the opium poppy; they include morphine and codeine.  Morphine was first isolated in 1805 by 
F.W.A. Sertürner, a German pharmacy assistant; he named it after Morpheus, the Greek god of 
dreams.  Opioids are semisynthetic or fully synthetic derivatives of opiates.  Semisynthetic 6-
keto-opioids include hydrocodone, hydromorphone, oxycodone, and oxymorphone.  Synthetic 
opioids include fentanyl, methadone, and buprenorphine.  Opiates and opioids are alkaline in 
nature, so they are best extracted in basic conditions.  To achieve the requisite chromatographic 
separation, and to generate better-defined mass spectra, derivatization by acylation or silylation 
is generally required for compatibility with GC/MS.  However, caution should be taken when 
using silylation, because the 6-keto-opioids have the potential to produce multiple derivatives as 
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a result of their keto- or enol forms.  (Beale & Block, 2011; Hutchings & Widdop, 2013; Corey, 
Czakó, & Kürti, 2007; Bogusz, 2008; Hedlund, 2018). 
Heroin/6-MAM 
 Heroin is a narcotic analgesic that causes the same effects as opiates and opioids, but with 
a much stronger addiction potential.  Heroin is a semisynthetic opioid with no accepted medical 
use; it is extremely prone to illicit abuse.  Heroin was first synthesized in 1898 by Bayer as a 
(hopefully) non-addictive alternative to morphine; it was named heroin because it made the test 
subjects feel heroic.  Heroin rapidly metabolizes in the body and is identified by its primary 
metabolite, 6-monoacetylmorphine (6-MAM).  6-MAM is alkaline in nature, so it is best 
extracted in basic conditions.  Like opiates and opioids, 6-MAM generally requires derivatization 
by acylation or silylation for compatibility with GC/MS in order to achieve the requisite 
chromatographic separation and to generate better-defined mass spectra.  (Beale & Block, 2011; 
Hutchings & Widdop, 2013; Bogusz, 2008). 
THC/THC-COOH 
 Delta-9-tetrahydrocannabinol (THC) is the primary psychoactive component of 
marijuana (cannabis), and is a depressant-intoxicant; it causes vigilance, drowsiness, delayed 
reaction time, divided attention, poor coordination and balance, bloodshot eyes, increased heart 
rate, and increased appetite.  Prolonged use of THC can lead to dysphoria, hallucinations, and 
paranoia.  The medico-legal status of THC is complicated.  Federally, it does not have an 
accepted medical use and is illegal; at the state level, it depends on the state.  Some states have 
implemented the acceptance of “Medical Marijuana”, whereby individuals may use marijuana 
for the treatment of various ailments, including cancer chemotherapy (as an antinauseant), 
asthma, multiple sclerosis, and glaucoma.  Some states have decriminalized marijuana 
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altogether, while some states still consider it to be illegal, per federal guidelines.  Amid this 
everchanging medico-legal landscape, THC is prone to abuse, whether it be by medical use, by 
decriminalized recreational use, or by illicit use.  THC is generally identified by both THC 
(parent drug) and its primary metabolite 11-nor-9-carboxy-THC (THC-COOH), though it can 
also be identified by several other metabolites.  THC and THC-COOH are acidic in nature, so 
they are best extracted in acidic conditions.  THC-COOH contains a carboxylic acid group, 
which means it has the potential to form strong hydrogen bonds with components in the 
chromatographic system, causing peak loss or tailing.  Therefore, samples generally require 
derivatization by silylation or acylation for compatibility with GC/MS.  Derivatization by 
acylation has been shown to improve the limit of detection for THC-COOH in negative chemical 
ionization GC/MS applications.  (Beale & Block, 2011; Hutchings & Widdop, 2013; Lin, et.al., 
2008; Lin, et.al., 2016). 
Alcohol Quantitation 
 In forensic laboratories, the first step of a DUI/DUID workflow typically involves the 
quantitation of blood alcohol concentration.  The instrumentation that is primarily used for the 
quantitation of blood alcohol concentrations is headspace gas chromatography flame-ionization 
detection (HS-GC/FID).  Though this method is the industry standard, it does not provide mass 
spectral confirmation, thereby requiring some forensic labs to run additional confirmation tests.  
By contrast, headspace gas chromatography flame-ionization detection mass spectrometry (HS-
GC/FID/MS) has all of the capabilities of HS-GC/FID, with the added benefit of spectral 
confirmation, thus eliminating the need for additional confirmation tests.  This section will 
include a description of HS-GC/FID and HS-GC/FID/MS, as well as an assessment of each 
instrument against the following parameters: instrument set-up, sample preparation, instrument 
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results, and data analysis.  Instrument performance in relation to these parameters will be 
evaluated as part of the analytical efficiency discussion.  (Sithersingh & Snow, 2012; Restek, 
2000; Agilent, n.d.). 
Headspace Gas Chromatography Flame-Ionization Detection – Presently-Applied Technique 
Headspace Gas Chromatography Flame-Ionization Detection is the industry standard for 
blood alcohol quantitation.  HS-GC/FID can be executed one of two ways: static or dynamic.  
Static HS-GC/FID is the method most commonly employed for forensic analyses, whereby the 
instrument samples the vapor phase of an equilibrated sample, and then injects the vapor directly 
into the chromatographic column(s) for separation.  The flame ionization detector measures the 
response of the analytes, and this response is then used for quantification of blood alcohol 
concentration.  (Thermo Fisher Scientific, n.d.; Sithersingh & Snow, 2012; Agilent 
Technologies, n.d.). 
What makes this technique unique, and ideal for the analysis of blood alcohol 
quantitation, is the headspace sampling, also referred to as headspace extraction.  Headspace 
extractions rely on the volatility of target analytes, such as ethanol, which has a low boiling point 
(78 ºC).  The other drugs/drug classes reviewed are not typically analyzed in this fashion because 
they do not meet the volatility requirements.  In headspace extractions, sealed sample vials are 
heated at a specified temperature for a specified time; this is to move analytes from the liquid 
sample into the vapor phase.  Once sample/vapor phase equilibrium is achieved, the 
concentration of the volatile analyte is constant across both the liquid and vapor phases.  This 
equilibrium allows for the extraction of the vapor phase, and the direct correlation of the 
concentration in the vapor phase to the liquid sample.  (Sithersingh & Snow, 2012; Restek 
Corporation, 2000; Beale & Block, 2011). 
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Instrument Set-up:  Instrument set-up can be divided into two categories method 
development and method validation. 
Method development involves the selection and programing of instrument parameters for 
HS-GC/FID instruments; parameters include equilibration time and temperature, injection 
method, column selection, temperature gradient, and optimization of sample preparation.  Some 
instrument manufacturers sell HS-GC/FID instruments that have been pre-configured for the sole 
purpose of blood alcohol quantitation.  This pre-configuration, in combination with the resources 
available on the websites of most instrument manufacturers, minimizes the time and effort 
required for method development.  (Sithersingh & Snow, 2012; Appendix A – Instrument 
Manufacturer Analysis). 
Equilibration time and temperature are important factors to optimize during method 
development, as extended exposure to equilibration temperatures may cause analyte degradation.  
Additionally, if sample/vapor phase equilibrium is not achieved, vapor concentration cannot be 
accurately correlated back to sample concentration.  (Tiscione et.al., 2011; Sithersingh & Snow, 
2012). 
An important aspect of instrument set-up is the selection of the injection method used to 
inject the sample into the chromatographic column; this is critical to the repeatability and quality 
of the resulting chromatogram.  Traditionally, a gas tight syringe (GTS) was used for this 
transfer step.  GTSs are the simplest, easiest, and most inexpensive method used for retrofitting 
standard GCs into headspace-GCs.  This method is no longer favored because it does not 
produce acceptable repeatability; this is likely due to sample loss caused by samples 
recondensing in syringes that are not equilibrated to the same temperature as the sample vials.  
Transfer-line-based systems, also called balanced-pressure systems, are used for sample injection 
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with a high degree of repeatability.  However, this method does not inject a quantifiable sample 
volume into the system, which makes it less than ideal for forensic analysis.  The injection 
method used by most headspace samplers intended for forensic use is the sample-loop system, 
also called the pressure-loop system.  This method employs the use of a pressurized loop system 
to inject a known volume of sample; reproducibility is improved by the use of the fixed volume 
loop.  (Sithersingh & Snow, 2012; Restek Corporation, 2000). 
Typically, HS-GC/FID uses capillary columns, which are generally 30-meters.  The 
internal diameters and widths of the stationary phase vary depending on the column.  Columns 
affect analyte separation and retention time.  Another factor that affects analyte separation and 
retention time is the oven temperature.  Runs can be isothermal, or can be run on a temperature 
gradient.  When developing methods, labs need to select an appropriate column, and then 
optimize the temperature gradient to be used in order to effect quality separation.  (Sithersingh & 
Snow, 2012; Restek Corporation, 2000; Kaya, et.al., 2011; Cooper, Riccardino, & Cojocariu, 
2019). 
After instrument methods have been developed, they must be validated prior to use for 
casework.  According to the Standard Practices for Method Validation in Forensic Toxicology, 
written by the Academy Standards Board (ASB), “Validation is the process of performing a set 
of experiments to establish objective evidence that a method is fit-for-purpose and to identify the 
method’s limitations under normal operating conditions.”  Validation parameters for quantitative 
forensic analyses at minimum must include: bias, calibration model, carryover, interference 
studies, ionization suppression/enhancement (for applicable techniques, such as LC/MS), limit of 
detection (LOD), limit of quantitation (LOQ), precision, dilution integrity (if applicable), and 
processed sample stability (if applicable).  (Academy Standards Board, 2019). 
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Carryover is the potential for a sample with a high concentration to contaminate the 
sample(s) that come after it.  If carryover is not properly assessed during validation, it has the 
potential to cause false positives (erroneous results).  Carryover is evaluated by running blank 
samples after samples with high concentrations, typically the highest calibrator.  If the blank 
samples don’t show a response above the method’s LOD, then the carryover assay is acceptable.  
If carryover is observed, then modifications need to be made to the method to remove or reduce 
carryover.  Carryover can be minimized by purging the sample loop, by increasing the injection-
port temperature, or by baking-out the oven.  (Academy Standards Board, 2019; Restek 
Corporation, 2000). 
Interference is the potential for the sample matrix, the stable-isotope internal standards, or 
other commonly-encountered analytes, such as over-the-counter medications, to hinder the 
effectiveness of an analytical method.  Alcohol quantitation does not typically involve the use of 
stable-isotope internal standards.  Matrix interference can be reduced by the sample preparation 
method used.  Interference from other analytes can be tested in a variety of ways; for alcohol 
quantitation, a mixed alcohol calibration working standard is typically used.  This standard 
includes typical volatile organic compounds that have the potential to be partitioned into the 
headspace and interfere with the analysis.  Analytes may include methanol, ethanol, acetone, 
isopropanol, acetonitrile, ethyl acetate, and 1-propanol.  Depending on the column and the 
chromatographic method used, these analytes have different, known retention times and can be 
effectively differentiated from one another.  (Academy Standards Board, 2019; Cooper, 
Riccardino, & Cojocariu, 2019). 
According to the ASB, labs have the option of either making their lowest non-zero 
calibrator, or using the decision point to define both their LOD and LOQ.  This appears to be a 
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common practice for blood alcohol quantitation, with 0.02 g/dL being the decision point.  This 
use of a non-zero calibrator, or decision point LOQ, could explain why many states have a limit 
of 0.02 g/dL for DUI drivers under 21; the LOQ of their tests is likely 0.02 g/dL.  (Academy 
Standards Board, 2019; Cooper, Riccardino, & Cojocariu, 2019; Nolo, n.d). 
Sample Preparation:  HS-GC/FID sample preparation is relatively simple for a 
chromatographic technique, because the only sample preparation that is required is the addition 
of a known concentration of internal standard (IS), to a known volume of matrix in a headspace 
vial.  The vial is then crimped closed to trap the vapor phase in the vial, and is ready for 
instrumental analysis.  Alcohol quantitation does not typically require derivatization.  The 
volume of biological sample used may vary from lab to lab, but it can be less than 1 mL.  The IS 
used, and the concentration of the IS varies from lab to lab, but it is typically a volatile organic 
compound (VOC), similar to those described in the interference study.  Standards, QCs, and 
blanks are included in the instrument run in addition to the case sample(s).  (Cooper, Riccardino, 
& Cojocariu, 2019; Kaya, et.al., 2011). 
Instrument Results:  HS-GC/FID instruments can be constructed with a single-column or 
dual-column configuration.  Some forensic labs use dual-column systems with two columns of 
different chemistries and selectivities to change the elution order and/or retention times of 
analytes.  This technique enables the second column to be used for the qualitative confirmation 
of alcohol.  (Cooper, Riccardino, & Cojocariu, 2019; Restek Corporation, 2000). 
When calculating the time required to run a sample, it is important to remember that 
headspace analyses require an incubation period prior to GC analysis.  Incubation time, and the 
time required for the chromatographic run can vary from lab to lab and instrument to instrument.  
Cooper, Riccardino, & Cojocariu incubated for 15 minutes and had a run time of 5 minutes.  
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Kaya, et.al. incubated for 10 minutes and had a run time of 6 minutes.  Ghorbani, et.al. incubated 
for 15 minutes and had a run time of 12 minutes.  Restek Corporation incubated for 15 minutes 
and had a run time of 3 minutes.  Shimadzu incubated for 13 minutes and had a run time of 5.5 
minutes.  These studies used different incubation temperatures, different columns, and different 
temperature gradients.  All were able to reliably quantitate and identify ethanol in less than 30 
minutes.  (Cooper, Riccardino, & Cojocariu, 2019; Kaya, et.al., 2011; Ghorbani, et.al., 2018; 
Restek Corporation, 2000; Shimadzu Corporation, 2019). 
Data Analysis:  The type of data obtained in a HS-GC/FID analysis is a chromatogram.  
Data is generally processed using integration software that comes with the instrument.  Software 
is generally specific to instrument brands; for example, Agilent instruments use ChemStation, 
and Thermo Fisher Scientific instruments use Chromeleon.  Though software may be used to aid 
data analysis, manual review and verification of results are essential.  Labianca describes a case 
where the results produced by integration software were not manually verified; this caused the 
case to be acquitted.  In this instance, the calibration curve produced by the software did not have 
an acceptable linearity, which caused an inaccurate calculation of the blood alcohol 
concentration of the case sample.  (Cooper, Riccardino, & Cojocariu, 2019; Ghorbani, et.al., 
2018; Labianca, 2015). 
The ethanol peak is identified by retention time; when using a dual-column system, 
ethanol should have different retention times on the two columns, and can be qualitatively 
confirmed if both retention times match the reference.  After qualitative analyte identification 
comes quantitation.  The standards are used to build a calibration curve, and the QCs are used to 
verify the accuracy of the curve.  Typically, a run will include at least one positive and one 
negative QC.  Once QCs are determined to be acceptable, the case samples are then compared to 
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the curve, and samples above cutoff are quantitated.  (Cooper, Riccardino, & Cojocariu, 2019; 
Ghorbani, et.al., 2018; Labianca, 2015). 
Headspace Gas Chromatography Flame-Ionization Detection Mass Spectrometry – Emerging 
Technique 
 Headspace Gas Chromatography Flame-Ionization Detection Mass Spectrometry is the 
progeny of HS-GC/FID and GC/MS.  HS-GC/FID/MS is a hybrid instrument that allows for a 
single injection to provide simultaneous quantification (FID) and spectral confirmation (MS).  
This hybridization is achieved by the installation of a two-way splitter, similar to a Dean’s 
Switch, to the terminal end of the chromatographic column.  The ends of the splitter are 
connected to the FID and MS in a 1:1 split ratio using deactivated columns.  (Agilent 
Technologies, n.d.; Tiscione et.al., 2011; Tiscione et.al., 2013). 
Instrument Set-up:  Instrument set-up for HS-GC/FID/MS is very similar to instrument 
set-up for HS-GC/FID, and can also be divided into two categories, method development and 
method validation. 
Method development for HS-GC/FID/MS also involves the selection and programing of 
instrument parameters, and includes equilibration time and temperature, injection method, 
column selection, temperature gradient, optimization of mass spectrometer parameters, and 
optimization of sample preparation.  For mass spectrometers analyzing in selected ion 
monitoring (SIM) mode, method development may also include the establishment and 
optimization of parameters for SIM analysis.  Some instrument manufacturers are now selling 
HS-GC/FID/MS instruments that have been pre-configured for blood alcohol quantitation.  This 
pre-configuration, in combination with the resources available on the websites of many 
instrument manufacturers, minimizes the time and effort required for method development.  
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(Sithersingh & Snow, 2012; Shimadzu Corporation, n.d.; Appendix A – Instrument 
Manufacturer Analysis). 
The validation requirements for HS-GC/FID/MS are the same as those for HS-GC/FID, 
and at minimum must include bias, calibration model, carryover, interference studies, ionization 
suppression/enhancement (for applicable techniques, such as LC/MS), LOD, LOQ, precision, 
dilution integrity (if applicable), and processed sample stability (if applicable).  (Academy 
Standards Board, 2019). 
 Sample Preparation:  Sample preparation for HS-GC/FID/MS is the same as that for HS-
GC/FID, including the use of a VOC IS.  HS-GC/FID/MS also includes standards, QCs, and 
blanks in the instrument run.  (Tiscione, et.al., 2011). 
 Instrument Results:  The MS analysis of HS-GC/FID/MS methods can be performed in 
one of two analysis modes, full-scan (scan) or SIM.  Scan mode is used for both qualitative and 
quantitative analysis, and is a full ion scan.  SIM mode is typically used for quantitative analysis; 
it requires prior knowledge of the specific masses to be measured; this gives it much better 
sensitivity than scan mode.  Since HS-GC/FID/MS analysis uses the MS for the qualitative 
identification of ethanol, scan mode is generally used.  (Shimadzu Corporation, n.d.; Tiscione, 
et.al., 2011). 
Since HS-GC/FID/MS is an extension of HS-GC/FID, the time required for sample 
equilibration and run time is approximately the same.  Tiscione, et.al. incubated for 20 minutes 
and had a run time of 8.5 minutes, thus enabling them to quantify ethanol concentration and 
qualify ethanol via spectral confirmation in less than 30 minutes.  (Tiscione, et.al., 2011). 
 Data Analysis:  Data analysis of the FID data is the same as that for HS-GC/FID.  Like 
the FID data, the MS data is also processed using integration software; the same software is 
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typically used to process both types of data.  Scan mode produces a total ion chromatogram 
(TIC); the peaks on the TIC can be selected, and the mass spectrum is viewed.  Retention time 
and mass spectral confirmation are used for qualitative confirmation of ethanol.  Spectral 
confirmation occurs when the ratios of diagnostic ions, those that reveal distinctive information 
about the target analyte, either match those of a reference standard or they match a library 
spectrum at a defined match factor.  Manual verification of results produced by software is 
required.  (Shimadzu Corporation, n.d.; Tiscione, et.al., 2011; Academy Standards Board, n.d., 
Standard for Identification Criteria in Forensic Toxicology; Academy Standards Board, n.d., 
Standard for Mass Spectral Data Acceptance in Forensic Toxicology). 
Immunoassay Screening 
 In forensic laboratories, if alcohol is identified and quantified above the legal limit, often, 
no other tests are performed.  If alcohol is not identified, or is not quantified above the legal 
limit, then further testing is performed.  This further testing includes immunoassay screening, 
which is typically the enzyme-linked immunosorbent assay (ELISA), but may be a different type 
of immunoassay, such as the enzyme multiplied immunoassay technique (EMIT).  This section 
will include a description of traditional immunoassays and Biochip Array Technology (BAT), as 
well as an assessment of each analytical system against the following parameters: instrument set-
up, sample preparation, instrument results, and data analysis.  System performance in relation to 
these parameters will be evaluated as part of the analytical efficiency discussion.  (Logan, et.al., 
2017; Monroe, 1984; Randox Laboratories, n.d.). 
Traditional Immunoassays – Presently-Applied Techniques 
 Immunoassays are screening tools that utilize analyte-specific antibodies to 
presumptively identify the drugs/drug classes present in a sample.  Whenever xenobiotics are 
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consumed, the body registers those invasive substances as antigens, and then deploys antibodies 
to counteract the effects of the antigens.  Some antibodies are antigen specific for those 
comprised of certain molecular configurations.  When an antibody attacks an antigen, an immune 
complex bond is formed; the formation of this bond is what is used to identify drugs/drug classes 
in unknown samples.  In enzyme immunoassays, the antibodies or antigens that are used for 
these reactions may be enzyme labeled; this enzyme labeling is used to colorimetrically measure 
the concentration of the target analyte in the sample.  (Datta, 2019; Monroe, 1984; Vashist & 
Luong, 2018; Immunalysis Corporation, 2016-2018). 
 Immunoassays used for drug screening are typically direct competitive assays.  They 
utilize the competitive binding of the antibody by both the enzyme labeled antigens (in the 
reagents) and unlabeled antigens (in the sample matrix).  Theoretically, competitive assays can 
be developed for any analyte.  These assays are typically either homogenous or heterogenous.  In 
homogenous assays, such as EMIT, the separation of excess enzyme-labeled antigens is not 
necessary.  Concentration in homogenous assays is directly proportional to the measured enzyme 
activity.  In heterogenous assays, such as ELISA, the separation of excess enzyme-labeled 
antigens is necessary, and requires the inclusion of a wash step(s) prior to signal measurement.  
Concentration in heterogenous assays is inversely proportional to the measured enzyme activity.  
(Datta, 2019; Monroe, 1984; Vashist & Luong, 2018; Immunalysis Corporation, 2016-2018; Cox 
& Baum, 1998; Sundström, Pelander, & Ojanperä, 2014; Engvall, 1980). 
 This review will focus primarily on ELISA immunoassays, as they are the ones 
predominantly used by forensic labs.  This predominance is likely because ELISA assays are 
what the National Safety Council’s Alcohol, Drugs and Impairment Division recommends for 
screening blood.  The results of the previously-mentioned toxicology survey that was part of the 
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Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle 
Fatalities – 2017 Update, listed ELISA as the primary screening method.  Of the laboratories 
surveyed, 74% reported the use of ELISA as their screening method for drugs in blood, while 
11% reported the use of EMIT for screening blood for drugs; other labs also reported the use of 
various chromatographic methods for screening.  (Logan, et.al., 2017). 
 Instrument Set-up:  Because most immunoassays come in a semi-automated or fully-
automated analytical system, there is not usually a method development step.  Tests typically 
come in the form of a kit that provides the reagents, calibrators, and QCs necessary to perform a 
specific assay.  However, if labs choose to employ the use of an automated liquid handling 
system, such as a TECAN Genesis liquid handling workstation, additional programing and 
regular calibration may be required.  (Immunalysis Corporation, 2016-2018; Xie, et.al., 2004). 
 The validation requirements for immunoassay screening are quite simple as they only 
include LOD, precision (at the decision point), and processed sample stability (if applicable).  
Often, labs may choose to use the manufacturer recommended cutoff as both the LOD and 
decision point for immunoassays.  Since most immunoassays used for forensic purposes use a 
zero calibrator and a cutoff calibrator, the concentration of the cutoff calibrator is the 
manufacturer recommended cutoff, and is used for both the decision point and the LOD.  In this 
instance, labs are required to validate the LOD of all cross-reactive analytes in the same drug 
class that have cross-reactivity lesser than the target drug.  For example, if an opiates assay uses 
morphine as the target analyte, but the lab wants to claim the potential for detecting 
hydromorphone (cross-reactivity of 50% in blood) with this assay, the lab must validate its 
ability to detect hydromorphone at double the cutoff of the opiates assay.  However, this is not 
required for drugs that have cross-reactivities higher than the target drug.  Continuing with the 
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example of the opiates assay, this means that codeine (cross-reactivity of 200% in blood), does 
not require additional validation because it is detected below the cutoff of the opiates assay.  If 
labs choose to use a concentration other than the manufacturer recommendation as their decision 
point, additional LOD validation is required.  (Academy Standards Board, 2019; Immunalysis 
Corporation, 2016-2018). 
 Sample Preparation:  Sample preparation for immunoassays generally involves the use of 
an unaltered sample matrix, or the dilution of a sample matrix with buffer.  After this step, 
samples are ready for analysis on fully-automated instruments.  Semi-automated instruments 
may require additional steps involving the addition of reagents, incubation, and wash steps.  
However, it is not uncommon for labs to utilize automated liquid handling systems to turn semi-
automated assays into fully-automated assays.  The volume of sample required for 
immunoassays is generally assay specific, but is usually quite low (10-75 µL).  Immunoassays 
also require calibration, usually a single calibrator at the decision point, as well as positive and 
negative QCs.  (Tiscione & Wegner, 2017; Immunalysis Corporation, 2016-2018; KPL, 2013; 
Xie, et.al., 2004). 
 Instrument Results:  Typically, immunoassays are designed to target a specific drug or 
drug class, which means that a sample is usually tested with multiple immunoassays.  Even then, 
a single immunoassay may not cover an entire drug class.  For example, the opiates/opioids drug 
class includes several different sub-classes of opiates/opioids.  There is not an all-inclusive 
immunoassay that can be used to test for opiates, semi-synthetic opioids, and fully synthetic 
opioids.  Typically, an opiates assay is required for opiates and some of the semi-synthetic 
opioids; it uses morphine as a target analyte, and the others have known cross-reactivities.  An 
oxycodone assay is required for oxycodone (target analyte), and oxymorphone (cross-reactive 
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species), and other semi-synthetic opioids.  Each of the fully synthetic opioids (fentanyl, 
methadone, and buprenorphine) require their own assays.  Amphetamine/methamphetamine is 
another drug class that may require the use of multiple assays to cover most of the target 
analytes.  The necessity for multiple assays to cover a single drug class is something that labs 
need to take into account when they are building immunoassay test panels.  (Immunalysis 
Corporation, 2016-2018). 
 Regarding the time required to perform immunoassays, the limiting step seems to be the 
required incubation period.  The incubation required for immunoassays is generally assay 
specific, but can range from 20-60 minutes.  Generally, fully-automated assays will produce 
results faster than semi-automated assays, because semi-automated systems may require manual 
addition of reagents and wash steps.  These are steps that can be performed faster and more 
accurately when automated.  (Immunalysis Corporation, 2016-2018; Xie, et.al., 2004). 
 Data Analysis:  Generally, immunoassay results come in the form of classifying analytes 
as detected or not detected in a sample.  Typical forensic laboratory DUI/DUID workflow will 
include a confirmation of the assays that are detected in the screen.  However, there is a chance 
that the screen results and confirmation results may not match up.  This is because 
immunoassays have a proclivity for erroneous results caused by interferences.  Interferences may 
be caused: by cross-reactivity of structurally similar compounds; by endogenous substances, 
such as binding proteins or autoantibodies; or by exogenous interactions, such as sample 
turbidity and incomplete washing during sample preparation.  False negative results can also be 
caused by the High-dose Hook Effect, which is a phenomenon whereby an extremely high 
concentration of an analyte alters antibody binding, thus causing an assay to produce a false 
negative result.  (Krasowski et.al., 2009; Tate & Ward, 2004; Academy Standards Board, 2018). 
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 What follows is a description of the potential for erroneous results, primarily interference 
caused by cross-reactivity, in the six drug/drug classes that were described previously.  This 
information is intended as a guide, and may not be true for all immunoassays because different 
manufacturers may use different antibodies to target antigens; thus, same analyte interference 
may vary for assays from different manufacturers.  (Tate & Ward, 2004; Krasowski et.al., 2009). 
Benzodiazepine immunoassays have some potential for erroneous results.  Not all assays 
are built to target the low dose benzodiazepines; this can result in false negative results.  
Additionally, oxaprozin, nefopam, and sertraline are known to cross-react with benzodiazepine 
assays and cause false positive results.  (Dasgupta, 2019; Krasowski, et.al., 2009). 
 Amphetamine/methamphetamine immunoassays are rife with erroneous results.  Drugs 
derived from phenethylamine are the most common causes of false positives; these include 
several over-the-counter drugs such as ephedrine and pseudoephedrine.  The optical isomers of 
amphetamine and methamphetamine also have the potential to cause false positives; for example, 
the use of a Vicks Inhaler has been identified in several studies.  Dietary weight loss products are 
also potential sources of false positive results, because many of the active drug ingredients 
metabolize to amphetamine.  Additionally, ranitidine, bupropion, and trazodone are known to 
cross-react with amphetamine/methamphetamine assays and cause false positive results.  
Interestingly, amphetamine/methamphetamine immunoassays may not be able to detect bath 
salts and other designer drugs structurally similar to amphetamine.  (Dasgupta, 2019; Hutchings 
& Widdop, 2013; Maharjan & Johnson-Davis, 2019). 
 Cocaine/benzoylecgonine immunoassays are fairly robust.  The only erroneous results 
noted in studies are from cross-reactivity related to the consumption of herbal teas from Latin 
America.  These teas are sometimes made with coca leaves, which contain trace amounts of 
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cocaine, which is then metabolized to benzoylecgonine.  (Maharjan & Johnson-Davis, 2019; 
Dasgupta, 2019; Krasowski, et.al., 2009). 
 Opiates/opioid immunoassays have some potential for erroneous results.  Opiate assays 
tend to have lesser cross-reactivity with semisynthetic 6-keto-opioids and practically no cross-
reactivity with synthetic opioids.  This lack of cross-reactivity with synthetic opioids is why most 
of them have drug specific immunoassays, which exhibit very little cross-reactivity with 
potentially interfering substances.  The poor cross-reactivity with some semisynthetic 6-keto-
opioids is why many labs have an oxycodone assay that is intended to cross-react with 
oxymorphone; an unintended cross-reactive substance is naloxone.  False positive opiate results 
have been linked to the consumption of poppy seed-containing foods, since poppy seeds contain 
morphine and codeine.  Additionally, rifampicin, naloxone, pholcodine, and certain 
fluoroquinolone antibiotics are known to cross react with opiate assays and cause false positive 
results.  (Maharjan & Johnson-Davis, 2019; Dasgupta, 2019; Krasowski, et.al., 2009). 
 Heroin/6-MAM immunoassays are fairly robust.  As mentioned previously, semisynthetic 
opioids have a lesser cross-reactivity for opiate immunoassays.  Additionally, since 6-MAM 
assays are drug specific, they exhibit very little cross-reactivity with potentially interfering 
substances, and practically no cross-reactivity with other opiates/opioids.  (Hutchings & Widdop, 
2013). 
 THC/THC-COOH immunoassays have some potential for erroneous results.  Marinol, 
synthetic marijuana, is known to cause positive marijuana results.  Additionally, efavirenz, 
niflumic acid, and nonsteroidal drugs, such as naproxen and ibuprofen, are known to cross-react 
with cannabis assays and cause false positive results.  (Maharjan & Johnson-Davis, 2019; 
Dasgupta, 2019). 
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Biochip Array Technology – Emerging Technique 
 In 2002, Randox Laboratories developed Biochip Array Technology (BAT), which 
utilizes the principles of ELISA on a microscale.  Instead of using a 96 well plate to perform a 
battery of immunoassays, a single biochip (9x9mm) acts as the reaction vessel for a variety of 
immunoassays.  Biochips are composed of up to 49 discrete test regions (DTRs), including four 
internal quality control DTRs, one visual reference DTR, and 44 DTRs which are used for 
simultaneous multi-analyte testing.  Each DTR can contain analyte-specific antibodies for a 
drug/drug class immunoassay, thereby allowing up to 44 different screening tests to be 
performed on a single biochip concurrently.  (Randox Laboratories, n.d.; Randox Laboratories, 
2001; Randox Laboratories, 2014; Randox Laboratories, 2018). 
 Instrument Set-up:  Randox offers both semi-automated and fully-automated 
instrumentation for BAT; these assays include detection via a chemiluminescent light source, 
and a charge coupled device (CCD) camera and imaging system.  For their toxicology assays, 
Randox allows for user-defined (custom) cutoffs, in addition to their recommended cutoffs.  
(Randox Laboratories, n.d.; Randox Laboratories, 2018; Randox Laboratories, 2015). 
 The validation requirements for BAT are the same as those for immunoassay screening; 
they include LOD, precision (at the decision point), and processed sample stability (if 
applicable).  Alvarez, et.al. and Castaneto, et.al. determined that BAT assay performance could 
be optimized for improved detection when the manufacturer recommended cutoffs were 
increased.  Labs using custom cutoffs are required to perform additional LOD validation for 
analytes with cross-reactivities at or below the target analyte.  Continuing with the previous 
example of the opiates assay, this means that codeine (cross-reactivity of 200% in blood) would 
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require validation of the ability to detect codeine at half the cutoff of the opiates assay.    
(Academy Standards Board, 2019; Alvarez, et.al., 2012; Castaneto, et.al., 2015). 
 Sample Preparation:  Sample preparation for BAT generally involves the use of an 
unaltered sample matrix, or the dilution of a sample matrix with buffer.  Following this step, 
samples are ready for analysis on the fully-automated instruments.  The semi-automated 
instrument requires additional steps involving the addition of reagents, incubation, and wash 
steps.  The volume of sample required for BAT is generally assay (biochip) specific, but is 
usually quite low, requiring as little as 7-25 µL per biochip.  BAT assays also require calibration 
as well as positive and negative QCs.  (McLaughlin et.al., 2012; McLaughlin et.al., 2019; 
Randox Laboratories, 2015; Randox Laboratories, 2018). 
Instrument Results:  Randox offers a variety of multiplexed biochips which allow for the 
simultaneous analysis of up to 22 drugs/drug classes in a single biochip.  Randox offers biochips 
with several different DOA (drugs of abuse) panels, and also offers custom arrays.  With custom 
arrays, labs are able to select up to 22 drugs/drugs classes they want included in their screening 
panel.  Since specific drugs may be abused somewhat regionally, the use of a custom array 
allows labs to test for the drugs/drug classes most often encountered in their region.  (Randox 
Laboratories, n.d.; Logan, et.al., 2017). 
In theory, the results for a biochip can be obtained within 60 minutes of the 
commencement of sample processing when using the semi-automated system; this time-frame 
includes a 30-minute incubation.  When using the fully-automated systems, results may be 
obtained within 55 minutes of the inception of testing, including a 30-minute incubation.  
(McLaughlin et.al., 2012; McLaughlin et.al., 2019; Randox Laboratories, 2015). 
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Data Analysis:  BAT results typically come in the form of classifying analytes either as 
detected or not detected in a sample, for each assay reported.  Randox instruments allow users to 
decide which tests to report, which means there may be tests that were performed on a biochip 
that were not reported.  Randox instruments store both reported and unreported data, which 
allows for the retrieval of previously unreported results; this data-mining capability allows for 
samples to be reassessed without requiring reanalysis on the instrument.  (Randox Laboratories, 
2015; Randox Laboratories, 2018; FitzGerald, et.al., 2005; Academy Standards Board, 2018). 
To reduce potential interference caused by cross-reactivity of structurally similar 
compounds and endogenous substances, biochips contain a scavenger antibody that has a high 
affinity for interfering substances, and a low affinity for target analytes.  In two studies of 
postmortem blood samples, McLaughlin et.al. found that less than 1% of the samples screened 
using BAT and confirmed via chromatographic methods gave false positive results.  False 
positive screen results were only seen in amphetamine assays, and were attributed to the 
decompositional state of the postmortem samples, exogenous interactions of putrefactive amines.  
There were also a few instances of false negative results, less than 1% of samples screened using 
BAT and confirmed via chromatographic methods.  These false negatives were attributed to the 
cutoffs of the BAT screen being above the cutoffs of the chromatographic confirmation methods.  
Alvarez, et.al. and Castaneto, et.al. found that false positives could be reduced by increasing the 
cutoffs of the assays.  Both studies increased the manufacturer recommended cutoffs anywhere 
from 5- to 20-fold, essentially moving the cutoffs into therapeutic ranges, versus the sub-
therapeutic ranges recommended by Randox.  (Randox Laboratories, 2018; McLaughlin et.al., 
2012; McLaughlin et.al., 2019; Alvarez, et.al., 2012; Castaneto, et.al., 2015). 
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Drug Confirmation and Quantitation 
Typical forensic laboratory DUI/DUID workflow includes: a confirmation of the 
drugs/drug classes that screen as detected; a review of the DRE analysis for drugs/drug classes 
that can’t be screened for; and confirmation testing for these substances.  Confirmation testing 
may be divided into two categories, systematic toxicological analysis, or targeted analyte 
analysis.  In systematic toxicological analysis, samples are prepared and analyzed in a fashion 
that is favorable for the qualitative analysis of a broad spectrum of substances, for example 
acidic drugs.  Depending on the laws of the locality where the testing is being performed, 
analytes that are qualified may additionally require quantitation.  In targeted analyte analysis, 
samples are prepared and analyzed in a fashion that is favorable for the qualitative and/or 
quantitative analysis of a single drug or drug class, (for example, lorazepam and/or 
benzodiazepines).  Depending on the technique used, qualification and quantitation may be 
performed simultaneously or independently.  This section will include a description of gas 
chromatography mass spectrometry (GC/MS) and liquid chromatography tandem mass 
spectrometry (LC/MS/MS), as well as an assessment of each instrument against the following 
parameters: instrument set-up, sample preparation, instrument results, and data analysis.  
Instrument performance in relation to these parameters will be evaluated as part of the analytical 
efficiency discussion.  (Kabir & Furton, 2012; Kostakis, Harpas, & Stockham, 2013; Sciex, 
2010). 
Gas Chromatography Mass Spectrometry – Presently-Applied Technique 
 Gas Chromatography Mass Spectrometry (GC/MS) is considered by many to be the gold 
standard for drug confirmation, because every analyte creates a unique spectrum.  GC/MS was 
developed in the 1950s, when two Dow Chemical Company researchers combined the separation 
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power of gas chromatography with the spectral identification capabilities of mass spectrometry.  
GC/MS was also simultaneously developed by two Philip Morris Incorporated researchers.  The 
Dow Chemical Company researchers used a fast mass spectrometer, while the Philip Morris 
Incorporated researchers used a slower mass spectrometer.  Importantly, none of these 
researchers patented GC/MS, thus allowing others to quickly adapt the method and make 
necessary improvements to allow the technology to go mainstream.  (Jones, 2019). 
 Gas chromatography is a separation technique where analytes in a sample interact with 
the chromatographic column while it is simultaneously being heated.  The analyte interactions 
with the column, in combination with the different boiling points of the analytes, cause 
separation.  Separation is observed by the elution of analytes at retention times.  After elution 
from the column, analytes enter the mass spectrometer where they produce a spectrum displaying 
ion peaks versus their relative concentrations.  Each analyte has a unique splitting pattern, 
creating a unique spectrum, which allows for the utilization of reference libraries to match 
unknown spectra with known standards.  (Thermo Fisher Scientific, n.d; Finkle, Taylor, & 
Bonelli, 1972; Kabir & Furton, 2012; Silverstein, Webster, & Kiemle, 2005). 
 Instrument Set-up:  Instrument set-up can be divided into two categories, method 
development and method validation. 
 Method development involves the selection and programing of instrument parameters for 
GC/MS instruments; parameters include column selection, temperature gradient, ionization 
method, and optimization of sample preparation.  For mass spectrometers analyzing in SIM 
mode, method development may also include the establishment and optimization of parameters 
for SIM analysis.  Some instrument manufacturers sell GC/MS instruments that have been pre-
configured for forensic toxicology analysis.  This pre-configuration, in combination with the 
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resources available on the websites of most instrument manufacturers, minimizes the time and 
effort required for method development.  (Kabir & Furton, 2012; Shimadzu Corporation, n.d.; 
Appendix A – Instrument Manufacturer Analysis). 
 Typically, GC/MS uses capillary columns; common lengths for columns are 10-15 
meters.  The internal diameters and widths of the stationary phase vary depending on the column.  
Packed columns have also been used for GC/MS analysis.  Columns affect analyte separation 
and retention time.  Column selection may also impact whether analyte derivatization is 
necessary or optional.  Runs can be isothermal or utilize a temperature gradient.  When 
developing methods, labs need to select an appropriate column, and then optimize the 
temperature gradient to be used in order to effect quality separation.  (Thermo Fisher Scientific, 
n.d.; Agilent Technologies, n.d.; Kabir & Furton, 2012; Schaaf, Gerhards, & Dobbeleer, 2018; 
Gujar, 2018; Lambing, Phillips, & Robarge, 2010; Finkle, Taylor, & Bonelli, 1972; Finkle, Foltz, 
& Taylor, 1974). 
MS ionization typically utilizes one of three gas-phase ionization methods, positive 
chemical ionization (PCI), negative chemical ionization (NCI), or electron impact ionization 
(EI).  EI is considered to be “hard ionization”, as it often causes substantial fragmentation.  PCI 
and NCI are considered to be “soft ionization”, as they tend to produce spectra with less 
fragmentation.  Traditionally, EI was the primary ionization method used, in-part due to the fact 
that it was the first ionization method available.  PCI is also frequently used for drug analysis 
because it allows for the easy identification of drugs and their metabolites.  NCI is gaining 
popularity in drug analysis, particularly for electrophilic molecules, such as THC-COOH, 
because it has been shown to lower the LOD.  Labs will generally choose the ionization method 
that produces the best results; this may involve a comparison among the different ionization 
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methods, or the selection of an ionization method for its compatibility with a certain library or 
database.  (Silverstein, Webster, & Kiemle, 2005; Gujar, 2018; Kabir & Furton, 2012; Quimby, 
2008; Schaaf, Gerhards, & Dobbeleer, 2018; Finkle, Foltz, & Taylor, 1974; Lin, et.al., 2008; Lin, 
et.al., 2016). 
After instrument methods have been developed, they must be validated prior to use for 
casework.  Validation parameters for qualitative forensic analysis at a minimum must include 
carryover, interference studies, ionization suppression/enhancement (for applicable techniques, 
such as LC/MS), LOD, and processed sample stability (if applicable). Validation parameters for 
quantitative forensic analyses require the previously listed qualitative parameters, and include the 
additional parameters of bias, calibration model, LOQ, precision, and dilution integrity (if 
applicable).  Though it is not a validation requirement, labs additionally need to develop 
acceptance criteria for the analysis of MS data.  These criteria must be used for validation, and 
for all case samples analyzed using the validated method.  (Academy Standards Board, 2019; 
Academy Standards Board, n.d., Standard for Identification Criteria in Forensic Toxicology; 
Academy Standards Board, n.d., Standard for Mass Spectral Data Acceptance in Forensic 
Toxicology, n.d.). 
As mentioned previously, carryover is the potential for a sample with a high 
concentration to contaminate the sample(s) that come after it.  If carryover is not properly 
assessed during validation, it has the potential to cause false positives (erroneous results).  
Carryover can be minimized by baking-out the oven or by column backflushing.  (Academy 
Standards Board, 2019; Quimby, 2008). 
As mentioned previously, interference is the potential for the sample matrix, for stable-
isotope internal standards, or for other commonly encountered analytes, such as over-the-counter 
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medications, to hinder the effectiveness of an analytical method.  Matrix interference can be 
reduced by the sample preparation method, used in combination with the optimization of GC 
parameters.  Interference from stable-isotope ISs can come from impurities in the standard of 
non-labeled compounds.  This is assessed by spiking a blank sample with IS, and then analyzing 
it for non-labeled compounds above the LOD.  Interference from other analytes can be tested in a 
variety of ways.  For drug qualification and quantification, this may involve an evaluation of 
matrix samples containing compounds that may interfere the assay, including structurally-similar 
compounds, common drugs of abuse and their metabolites, and over-the-counter drugs.  
(Academy Standards Board, 2019; Quimby, 2008). 
As mentioned previously, the ASB gives labs the option of either making their lowest 
non-zero calibrator, or using the decision point to define both their LOD and LOQ.  The National 
Safety Council’s Alcohol, Drugs and Impairment Division has recommended cutoffs for Tier I 
analytes, which can be used as the decision point to define both LOD and LOQ.  The survey 
accompanying these recommendations found that only 17% of surveyed labs were in compliance 
with these cutoffs, and an additional 52% were working toward compliance.  ASB also gives 
labs the option to estimate LOD using background noise, which may be achieved by the use of 
reference materials, statistical analysis of background, or a linear calibration curve.  Labs that are 
not testing at the recommended cutoffs for Tier I analytes may use this alternative approach to 
LOD estimation.  (Academy Standards Board, 2019; Logan, et.al., 2017). 
 Sample Preparation:  GC/MS requires labor-intensive sample preparation, which directly 
impacts the integrity and quality of chromatographic data.  Common extraction methods for 
blood were described previously; these included LLE, SPE, SPME, PPT, and a discussion on 
derivatization.  Because GC/MS does not work as well for analytes that are thermally instable, 
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highly polar, or semi-/non-volatile, analytes exhibiting one or more of these issues can 
sometimes be derivatized to coerce compatibility with GC/MS.  However, it should be noted that 
not all analytes are compatible with GC/MS.  During the description of drugs/drug classes, it was 
further communicated that derivatization is required or recommended for the specific drug/drug 
classes reviewed for a variety of reasons, including thermal instability of target analyte, 
achievement of requisite chromatographic separation, and generation of better-defined mass 
spectra.  The downside of derivatization is that it increases the complexity of the sample 
preparation process, as well as the length of time required for sample prep.  (Kabir & Furton, 
2012; Kostakis, Harpas, & Stockham, 2013; Lin, et.al., 2008; Lin, et.al., 2016). 
 Sample size can range from a few hundred microliters to a couple milliliters, and appears 
to be dependent on the extraction method being used.  Large sample volume requirements result 
when a concentration step is required.  The time required for sample preparation is also 
dependent on the extraction method and the simultaneous derivatization method that are being 
used; because GC/MS requires a clean sample matrix, this can be a long process, with sample 
prep taking several hours.  As discussed earlier, confirmation testing may take the form of 
systematic toxicological analysis or targeted analyte analysis; these different analyses may also 
affect the required sample size and the time required for sample preparation.  Standards, QCs, 
and blanks are included in the instrument run in addition to the case sample(s).  Qualitative 
analyses may only include a cutoff calibrator, while quantitative analyses will include a 
calibration curve for each analyte being quantified.  (Lambing, Phillips, & Robarge, 2010; 
Kostakis, Harpas, & Stockham, 2013; Raes, Verstraete, & Wennig, 2008; Jemal, 2000; Sciex, 
2010; Waters Corporation, n.d.). 
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 Instrument Results:  The MS analysis of GC/MS methods can be performed in one of 
three analysis modes scan, SIM, or fast automated scan/SIM mode (FASST).  Scan mode is used 
for both qualitative and quantitative analysis, and it is a full ion scan.  SIM mode is typically 
used for quantitative analysis; it requires prior knowledge of the specific masses to be measured, 
which gives it much better sensitivity than scan mode.  FASST mode acquires scan and SIM data 
simultaneously by rapidly switching back and forth between the modes.  FASST mode works 
very well for multi-analyte qualitative methods, because the SIM mode identifies analytes that 
may have low sensitivity and may be missed in scan mode, while scan mode identifies 
compounds that may be overlooked in SIM mode.  The type of assay being performed 
determines the type of analysis mode used.  (Shimadzu Corporation, n.d.; Quimby, 2008). 
GC/MS typically requires a relatively long analysis time of 10 – 60 minutes per sample; 
however, attempts are being made to shorten analysis time with the innovation of fast GC.  Fast 
GC attempts to shorten run time by manipulation of the chromatographic parameters, without 
sacrificing chromatographic separation.  Quimby reported the use of a fast GC run with an MS 
that was simultaneously collecting full scan and SIM data; this method screened for 725 target 
compounds in 9.75 minutes.  (Kabir & Furton, 2012; Quimby, 2008). 
 Data Analysis:  GC/MS data is generally processed using integration software that comes 
with the instrument.  Software is generally specific to instrument brands; for example, Agilent 
instruments use ChemStation, and Thermo Fisher Scientific instruments use Chromeleon.  
Deconvolution software may also be used to aid data analysis of full scan data; Automated Mass 
Spectral Deconvolution & Identification System (AMDIS) is a deconvolution program 
developed by the National Institute of Standards and Technology (NIST).  AMDIS uses 
computational techniques to produce “cleaned spectra” by the extraction of target spectra from 
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overlapping interference peaks; this produces spectra that are more compatible with library 
searching.  (Cooper, Riccardino, & Cojocariu, 2019; Ghorbani, et.al., 2018; Quimby, 2008). 
Analyte identification is a combination of retention time and mass spectral confirmation.  
Scan mode produces a total ion chromatogram (TIC); the peaks on the TIC can be selected, and 
the mass spectrum is viewed and run through a library.  Spectral confirmation occurs when the 
ratios of diagnostic ions, those that reveal distinctive information about the target analyte, either 
match those of a reference standard or match a library spectrum at a defined match factor.  
Instruments that analyze in scan mode may have data mining capabilities.  SIM mode evaluates 
samples for pre-established target and qualifier ions for each target analyte; each analyte will 
typically have at least three selected ions.  Spectral confirmation occurs when observed 
diagnostic ion ratios agree with calculated ion ratios from a reference standard that is 
concurrently analyzed.  Manual verification of results produced by software is required.  
(Shimadzu Corporation, n.d.; Quimby, 2008; Academy Standards Board, n.d., Standard for 
Identification Criteria in Forensic Toxicology; Academy Standards Board, n.d., Standard for 
Mass Spectral Data Acceptance in Forensic Toxicology; Lambing, Phillips, & Robarge, 2010). 
Once qualitative analyte identification is complete, quantitation follows, when applicable.  
The standards are used to build a calibration curve, and the QCs are used to verify the accuracy 
of the curve.  Typically, a run will include at least one positive and one negative QC.  Once QCs 
are determined to be acceptable, the case samples are then compared to the curve, and samples 
above cutoff are quantitated.  (Lambing, Phillips, & Robarge, 2010; Quimby, 2008). 
Liquid Chromatography Tandem Mass Spectrometry – Emerging Techniques 
 The use of Liquid Chromatography Tandem Mass Spectrometry in clinical laboratories 
has increased substantially the last 20-25 years.  Presently, LC/MS/MS is successfully 
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penetrating forensic science laboratories because it addresses the need for spectral confirmation 
of analytes that are traditionally detected via HPLC.  (Grebe & Singh, 2011). 
 Liquid chromatography is a separation technique that employs the use of a column that is 
packed with a stationary phase, and typically two liquid mobile phases.  One liquid mobile phase 
is aqueous, and one is organic; these mobile phases propel samples through the column.  The 
analytes in the sample interact with both the stationary and mobile phases, thus causing 
separation.  Separation is observed by the elution of analytes at retention times.  After elution 
from the column, analytes enter the tandem mass spectrometer (MS/MS).  There are a variety of 
options available for MS/MS analysis of DUI/DUID samples; they include triple quadrupole 
(QQQ), quadrupole linear ion trap (QLIT or QTRAP®), and quadrupole time of flight (QTOF).  
(Thermo Fisher Scientific, n.d.; Kostakis, Harpas, & Stockham, 2013). 
It is important to note that while there are numerous options for detection methods, the 
same liquid chromatography techniques can be used with each of the different detection 
methods.  It is also important to note that QLIT and QTOF have the ability to analyze in both 
targeted and untargeted scan modes, with the scan mode used determining whether the results 
obtained are considered to be presumptive or confirmatory.  For forensic purposes, targeted 
scans are typically considered confirmatory and can be quantitated, while untargeted scans are 
typically considered presumptive, thus requiring additional confirmation.  The advantage of an 
untargeted screen is the ability to presumptively identify novel, synthetic, or designer drugs that 
would be missed in targeted screens.  The disadvantage of targeted screens is that one only finds 
what they are looking for.  (Academy Standards Board, n.d., Standard for Mass Spectral Data 
Acceptance in Forensic Toxicology; Marquet, 2002; Kostakis, Harpas, & Stockham, 2013; 
Fleming, et.al., 2016). 
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Instrument Set-up:  Instrument set-up can be divided into two categories, method 
development and method validation. 
Method development for LC/MS/MS is typically more labor intensive than for GC/MS, 
because instruments used in multiple reaction monitoring (MRM) mode require optimization for 
every precursor and product ion being targeted.  This is in addition to the selection and 
programing of other instrument parameters, such as column selection, mobile phase composition, 
mobile phase gradient, needle rinse, ionization method, and optimization of sample preparation.  
MS/MSs that are used in full scan or enhanced production ion (EPI) scan modes don’t generally 
require extensive method development; instead, they require optimization of scan criteria and 
information dependent acquisition (IDA) parameters.  Due to the more complex nature of 
LC/MS/MS, specifically the scheduling of MRMs, most LC/MS/MS instrument manufacturers 
do not offer preconfigured instruments.  Some manufacturers have developed methods or created 
MRM libraries that can be used as a starting point for LC/MS/MS method development; these 
tools may require an additional purchase.  Many manufacturers also offer resources on their 
websites that are intended to aid the method development process; these resources can include 
recommended sample preparation procedures, recommended LC conditions, and recommended 
MS/MS conditions.  Even with these resources, LC/MS/MS method development can be a 
tedious, time consuming process.  There are consultants who specialize in method development 
and validation of LC/MS/MS systems; they are an option, but add additional upfront cost.  
(Kostakis, Harpas, & Stockham, 2013; Lynch, et.al., 2010; Appendix A – Instrument 
Manufacturer Analysis). 
LC columns come in a variety of stationary phases and particle sizes; labs will select the 
column that is most compatible with the separation they are trying to perform.  The column most 
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commonly used for drug analysis is a reversed phase C18 column, though there are many 
different column options available for drug analysis, including biphenyl and phenyl-hexyl.  
Many LC systems also employ the use of a guard column to extend the life of the analytical 
column.  Guard columns precede analytical columns, and are typically composed of the same 
stationary phase and the same particle size as the analytical column.  Columns affect analyte 
separation and retention time.  Mobile phase selection is just as important to analyte separation 
as column selection.  LC systems employ the use of both aqueous and organic mobile phases that 
have been buffered; buffering mobile phases helps ensure retention time reproducibility.  Mobile 
phases are typically buffered with either formic acid or ammonium formate, though other agents 
may be used.  The organic mobile phase is typically methanol or acetonitrile.  Jemal found that 
runs using buffered water/methanol mobile phases gave a significantly higher response than runs 
using buffered water/acetonitrile mobile phases.  Runs can be either isocratic or utilize a gradient 
that changes the ratio of the aqueous and organic mobile phases during the run.  Gradient elution 
is used more commonly than isocratic elution, because gradient elution maximizes the separation 
of analytes across a wide polarity range.  When developing methods, labs need to select the 
appropriate column and mobile phases, and then optimize the mobile phase gradient to be used in 
order to effect quality separation.  (Kostakis, Harpas, & Stockham, 2013; Grebe & Singh, 2011; 
Jemal, 2000; Maurer, 2005; Eeckhaut, et.al., 2009; Narayanasamy, et.al., 2019; Sosienski, 2019; 
Kintz, et.al., 2005; Li, Wang, & Jenkins, 2016; Cabrices, et.al., 2019; Xu, et.al., 2007). 
MS/MS ionization typically utilizes one of three evaporative ionization methods positive 
electrospray ionization (ESI+), negative electrospray ionization (ESI-), or atmospheric pressure 
chemical ionization (APCI).  ESI+/- and APCI are both considered to be “soft ionization”, as 
they tend to produce protonated (M+) or deprotonated (M-) molecular ions.  ESI+/- is commonly 
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used to analyze a wide range of compounds, such as those in forensic analyses.  APCI is 
generally less sensitive than ESI+/- for forensically relevant compounds, though it has been 
shown that APCI is less susceptible to matrix effects.  ESI+ is the ionization method used most 
commonly, followed by APCI.  ESI- is best suited for the analysis of THC-COOH and 
barbiturates because these analytes ionize preferentially in ESI-.  Traditionally, ESI instruments 
were only able to be used in either positive or negative mode, which meant that if labs wanted to 
identify negative mode analytes, they needed to run samples twice.  Since running samples twice 
was not ideal, some labs choose to only analyze samples in positive mode.  More recently, ESI 
instruments have fast polarity switching capabilities, which allow for the analysis of samples in 
both ESI+ and ESI- almost simultaneously.  Labs will generally choose the ionization method 
that produces the best results, but the selection of an ionization method may also be based on its 
compatibility with a certain library or database.  (Silverstein, Webster, & Kiemle, 2005; 
Kostakis, Harpas, & Stockham, 2013; Maurer, 2005; Eeckhaut, et.al., 2009; Narayanasamy, 
et.al., 2019; Sosienski, 2019; Cabrices, et.al., 2019; Tran, et.al., 2017; He, et.al., 2015). 
Instruments that are being used in MRM mode require optimization for the precursor and 
product ions of each analyte tested in the panel.  First, the precursor ion of each target analyte 
must be identified.  Then the product ions for each precursor ion must be identified, and the two 
product ions that are unique to a precursor ion are selected and optimized.  Parameters optimized 
may include scan time, declustering potential (DP), collision energy (CE), and collision cell exit 
potential (CXP).  DP, CE, and CXP are fragmentor voltages that are used for collision induced 
dissociation (CID) fragmentation.  Many LC/MS/MS libraries are highly dependent upon CID 
fragmentation; as such, labs wishing to use those libraries will need to use fragmentation 
conditions that are similar to those used for the library.  It has been noted that LC/MS/MS 
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libraries are manufacturer specific because of the inter-instrument differences in the relative 
intensities of product ion spectra, even when similar CID conditions are used.  (Maurer, 2005; 
Jansen, Lachatre, & Marquet, 2005; He, et.al., 2015; Grebe & Singh, 2011). 
After instrument methods have been developed, they must be validated prior to use for 
casework.  Validation parameters for qualitative forensic analysis at a minimum must include 
carryover, interference studies, ionization suppression/enhancement (for applicable techniques, 
such as LC/MS), LOD, and processed sample stability (if applicable). Validation parameters for 
quantitative forensic analyses require the previously-listed qualitative parameters, and also 
include the additional parameters of bias, calibration model, LOQ, precision, and dilution 
integrity (if applicable).  Validation parameters for non-immunoassay presumptive screening 
analyses, include interference studies, LOD, and ionization suppression/enhancement (for 
applicable techniques, such as LC/MS).  Though it is not a validation requirement, labs 
additionally need to develop acceptance criteria and data analysis parameters for the analysis of 
MS/MS data.  These criteria must be used for validation, and for all case samples analyzed using 
the validated method.  Data analysis parameters are particularly important for untargeted scans 
because analyte identification is more dependent on data analysis rather than data collection.  
(Academy Standards Board, 2019; Academy Standards Board, n.d., Standard for Identification 
Criteria in Forensic Toxicology; Academy Standards Board, n.d., Standard for Mass Spectral 
Data Acceptance in Forensic Toxicology, n.d.; Colby, Thoren, & Lynch, 2018). 
As mentioned previously, carryover is the potential for a sample with a high 
concentration to contaminate the subsequent sample(s) tested.  If carryover is not properly 
assessed during validation, it has the potential to cause false positives (erroneous results).  In LC 
techniques, carryover is primarily controlled by the needle rinse; key variables are the solution 
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used for the rinse and the rinse sequence.  The needle is typically rinsed before and after 
injection, using a specified volume of needle rinse solution for a specified time, such as 1mL for 
5 seconds.  Needle rinse solution is typically composed of organic solvents, and may include 
acetonitrile, isopropanol, and methanol; solvent ratios may vary depending on the lab.  
(Academy Standards Board, 2019; Narayanasamy, et.al., 2019; Tran, et.al., 2017; He, et.al., 
2015; Verplaeste, et.al., 2013; Lynch, et.al., 2010). 
As mentioned previously, interference is the potential for the sample matrix, the stable-
isotope internal standards, or other commonly-encountered analytes, such as over-the-counter 
medications, to hinder the effectiveness of an analytical method.  Matrix interference will be 
discussed later in the ionization suppression/enhancement section.  Interference from stable-
isotope ISs can come from impurities in the standard of non-labeled compounds.  This is 
assessed by spiking a blank sample with IS, and then analyzing it for non-labeled compounds 
above the LOD.  Interference from other analytes can be tested in a variety of ways.  For drug 
qualification and quantification, this can involve an evaluation of matrix samples containing 
compounds that may interfere with the assay, such as structurally-similar compounds, common 
drugs of abuse and their metabolites, and over-the-counter drugs.  (Academy Standards Board, 
2019; Fleming, et.al., 2016). 
As mentioned previously, the ASB gives labs the option of either making their lowest 
non-zero calibrator, or using the decision point to define both their LOD and LOQ.  Also 
mentioned previously were The National Safety Council’s Alcohol, Drugs and Impairment 
Division’s recommended cutoffs for Tier I analytes, which can be used as the decision point to 
define both LOD and LOQ.  ASB also gives labs the option to estimate LOD using background 
noise, which may be achieved by the use of reference materials, statistical analysis of 
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background, or a linear calibration curve.  Labs that are not testing at the recommended cutoffs 
for Tier I analytes may use this alternative approach to LOD estimation.  (Academy Standards 
Board, 2019; Logan, et.al., 2017). 
Ionization suppression/enhancement, which is also referred to as matrix effects, is the 
phenomenon caused by co-eluting endogenous substances that enhance or suppress the co-
eluting target analyte.  Labs need to assess matrix effects, and demonstrate that they do not have 
an impact on other validation parameters, such as LOD and LOQ.  Matrix effects can be assessed 
by either post-column infusion or post-extraction addition.  It is important to note that the 
evaluation of matrix effects includes multiple different sources of blank matrix to account for 
common interferences.  Matrix effects can be reduced through several means, including 
modification of sample preparation, optimization of LC parameters, or the use of stable-isotope 
IS.  Matrix effects are, in part, dependent upon the type of biological fluid being analyzed, 
because endogenous substances found in the sample matrix are the cause of interference.  
Because the offending compounds are endogenous, matrix effects can sometimes be reduced by 
modification of sample preparation techniques.  Biological fluid specific matrix effects can also 
be ameliorated by the use of matrix matched standards and QCs.  Additionally, matrix effects 
can be reduced by optimizing chromatography; this includes improving analyte separation, and 
adjustment of the mobile phase gradient so that interfering substances elute either before or after 
all target analytes.  Stable-isotope IS can be used to compensate for matrix effects affecting the 
named analyte.  The stable-isotope IS and the named analyte need to be at least three mass units 
apart for this technique to be effective.  Limitations from this technique arise from the 
complication that not all compounds have stable-isotope IS.  (Academy Standards Board, 2019; 
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Grebe & Singh, 2011; Jemal, 2000; Maurer, 2005; Eeckhaut, et.al., 2009; Li, Wang, & Jenkins, 
2016; Casey et.al., 2020). 
Sample Preparation:  LC/MS/MS requires adequate sample preparation, because it 
directly impacts the integrity and quality of chromatographic data; however, it is not as sensitive 
to sample preparation as GC/MS.  Common extraction methods for blood were described 
previously; these included LLE, SPE, SPME, PPT, and a discussion on derivatization.  One of 
the hallmarks of LC/MS/MS is its compatibility with analytes that are not compliant with 
GC/MS because of their thermal instability, high polarity, or semi-/non-volatility.  This 
LC/MS/MS compatibility comes with the added benefit of not requiring derivatization, which 
reduces both the time required for sample preparation, as well as the potential for errors to be 
made during the preparation process.  (Kostakis, Harpas, & Stockham, 2013; Li, Wang, & 
Jenkins, 2016; Sciex, 2010; Cabrices, et.al., 2019; Maurer, 2005; Eeckhaut, et.al., 2009; Leung & 
Fong, 2014). 
Another sample preparation option that is unique to LC/MS/MS is fast-flow on-line 
extraction, also referred to as on-line SPE.  This allows for the direct injection of whole samples 
that have been spiked with IS pre-column.  This method process utilizes a specialized type of LC 
extraction column that acts as an SPE cartridge; this extraction column is in series with the 
analytical column.  The mobile phases act as the wash and elution solvents for the SPE process.  
A six-port switching valve allows for the materials removed in the wash step to be sent to waste 
instead of to the analytical column, and then sends the subsequent elution of target analytes onto 
the analytical column.  Like traditional SPE, there are many different sorbents that may be used, 
each with varying separation mechanisms, and a variety of solvent options.  The type of SPE 
cartridge or column used also determines if each sample injected requires a new cartridge, or if 
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the same column can be used for an entire analytical run.  The use of disposable cartridges can 
help reduce carryover.  There are also systems that include the on-column addition of IS, which 
allows for the direct injection of whole samples.  (Jemal, 2000; Xu, et.al., 2007). 
Sample size can range from 50 µL to a few hundred microliters, and appears to be 
dependent on the extraction method that is being used.  Smaller sample volumes can be used 
because LC/MS/MS has better sensitivity than GC/MS and does not require a concentration step.  
The time required for sample preparation is also dependent on the extraction method.  
LC/MS/MS sample preparation is generally faster than GC/MS sample prep because of the 
elimination of the derivatization step.  In the instance of on-line SPE, sample preparation time is 
negligible.  As discussed earlier, confirmation testing may take the form of systematic 
toxicological analysis or targeted analyte analysis; these different analyses may also affect the 
sample size and the time required for sample preparation.  Standards, QCs, and blanks are 
included in the instrument run in addition to the case sample(s).  Qualitative analyses may only 
include a cutoff calibrator, while quantitative analyses will include a calibration curve for each 
analyte being quantified.  (Xu, et.al., 2007; Li, Wang, & Jenkins, 2016; Sciex, 2010; Cabrices, 
et.al., 2019; Tran, et.al., 2017; Narayanasamy, et.al., 2019; Sosienski, 2019). 
QTOF instruments additionally require the use of a reference solution to calibrate the 
MS/MS so it can perform mass accuracy corrections.  The frequency of these mass calibrations 
can vary dramatically, for example, from every 40 seconds, to one for every sample, to every 5 
injections; it appears to be user determined.  Lockspray solution is a QTOF calibration solution 
sold by Waters; it uses leucine enkephalin as the calibrant for both positive and negative 
ionization modes.  Purine and hexakis(1H, 1H, 3H-tetrafluoropropoxy)-phosphazine are also 
common compounds used for QTOF calibration of positive and negative ionization modes.  
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(Bidny, et.al., 2016; Grapp, et.al., 2018; Sciex, n.d.; Kronstrand, et.al., 2014; Tsai, et.al., 2013; 
Broecker, et.al., 2011; Thoren, et.al., 2016). 
Instrument Results:  QQQ utilizes a targeted analysis process known as multiple reaction 
monitoring (MRM).  In the first quadrupole (Q1), precursor ions are filtered by their mass to 
charge (m/z) ratios.  Q2 is a collision cell in which product ions are created by collision induced 
dissociation (CID).  In Q3, product ions are filtered by their m/z ratios.  Each target analyte in an 
assay will have a specific product ion that is targeted in the MRM; this is referred to as a 
transition, and typically there are two transitions (product ions) monitored per precursor ion.  
MRM is a targeted analysis, and can only be used to detect analytes that are included in the 
method; it can be used for both qualification and quantitation.  (Sciex, 2012; Waters Corporation, 
n.d.; Marquet, 2002). 
QLIT has the ability to analyze samples in MRM mode, but can also utilize enhanced 
production ion (EPI) mode, an untargeted analysis.  EPI mode is an untargeted screen which can 
be used to scan for analytes that are not included in the method; it can be used for presumptive 
qualification.  In EPI mode, Q1 is used to filter precursor ions, and Q2 is used to create product 
ions by CID.  Q3 is used as a linear ion trap to perform a full scan of all product ions produced in 
Q2.  The resulting product ion scan can then be searched against a library to identify the analyte.  
Another common way QLIT is being used is in MRM mode, in conjunction with information 
dependent acquisition (IDA) and EPI mode; this is sometimes referred to as MRM-EPI, and is a 
targeted analysis.  Targeted precursor ions are analyzed in MRM mode, then IDA identifies ions 
that meet user-determined conditions, and then automatically follows the MRM scan with an EPI 
scan.  The resulting product ion scan can then be searched against a library to identify the 
analyte.  (Sciex, 2012; Sciex, 2014; Lynch, et.al., 2010; Thoren, et.al., 2016; Verplaeste, et.al., 
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2013; Sciex, 2020; Dresen, et.al., 2010; Herrin, McCurdy, & Wall, 2005; Jansen, Lachatre, & 
Marquet, 2005). 
QTOF typically analyzes samples in auto MS/MS mode, which is an untargeted analysis.  
Auto MS/MS mode first performs a full scan in MS mode, then IDA identifies ions that meet 
user-determined conditions, and then automatically follows the full scan with an MS/MS scan.  
The resulting auto MS/MS scan can then be searched against a library to presumptively identify 
the analyte.  Waters Corporation has developed a proprietary data independent QTOF acquisition 
mode called MSE, which is also an untargeted scan.  In MSE mode, precursor and product ions 
are produced and collected almost simultaneously.  Software is then used to deconvolute the data 
and organize it by retention time so it can undergo analysis.  In addition to auto MS/MS mode, 
some QTOF instruments also have the ability to analyze samples in MRM mode.  (Thoren, et.al., 
2016; Colby, Thoren, & Lynch, 2018; Broecker, et.al., 2011; Broker, Herre, & Pragst, 2012; 
Kronstrand, et.al., 2014; Waters Corporation, 2011; Grapp, et.al., 2018; Bidny, et.al., 2016; 
Sciex, n.d.). 
LC/MS/MS typically requires a shorter analysis time than GC/MS, typically less than 15 
minutes per sample.  Sosienski separated a 26-drug panel in 3.5 minutes.  He et.al. separated a 
93-drug panel in 6.5 minutes.  Sciex performed a study where it compared several GC/MS panels 
against LC/MS/MS panels, and found that LC/MS/MS run times could be as much as 65% faster 
than GC/MS run times.  The Sciex study was also able to combine opiate and 6-MAM panels 
into a single run, versus the two runs that would be required on GC/MS.  It was observed that 
articles written between 2000 and 2010 cited longer run times than articles written between 2010 
and 2020.  One reason for this could be improvements made in regard to HPLC and UHPLC 
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techniques.  (Kostakis, Harpas, & Stockham, 2013; Sosienski, 2019; He et.al., 2015; Sciex, 
2010). 
Data Analysis:  LC/MS/MS data is generally processed using integration software that 
comes with the instrument.  Software is generally specific to instrument brands.  Sciex uses 
SCIEX OS; Waters uses UNFI; Agilent uses MassHunter; and Thermo uses Xcalibur.  Due to the 
nature of the data gathered, LC/MS/MS data analysis is more time consuming than GC/MS data 
analysis.  This is because analyte identification is more dependent on data analysis rather than 
data collection for untargeted scans.  It is essential for labs to establish data analysis criteria.  
Data analysis can be aided by the optimization of library search criteria, however, all data must 
be manually reviewed and verified.  (Lynch, et.al., 2010; Cabrices, et.al., 2019; Kronstrand, 
et.al., 2014; Grapp, et.al., 2018; Alvarez, et.al., 2012). 
Analyte identification for targeted analyses depends on the analysis method used.  MRM 
mode requires analytes to have matching retention times and the presence of target product ions 
in at least two transitions.  Spectral confirmation occurs when observed diagnostic product ion 
ratios agree with calculated ion ratios from a reference standard that is concurrently analyzed.  In 
MRM-EPI mode, analyte identification is a combination of retention time, the presence of a 
single transition, and mass spectral confirmation.  MRM-EPI mode produces a product ion 
spectrum which can be viewed and run through a library.  Spectral confirmation occurs when the 
ratios of diagnostic product ions, either match those of a reference standard or match a library 
spectrum at a defined match factor.  (Academy Standards Board, n.d., Standard for Identification 
Criteria in Forensic Toxicology; Academy Standards Board, n.d., Standard for Mass Spectral 
Data Acceptance in Forensic Toxicology; Marquet, 2005; Thoren, et.al., 2016). 
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Once qualitative analyte identification is complete, quantitation follows, when applicable.  
The standards are used to build a calibration curve, and the QCs are used to verify the accuracy 
of the curve.  Typically, a run will include at least one positive and one negative QC.  Once QCs 
are determined to be acceptable, the case samples are then compared to the curve, and samples 
above cutoff are quantitated.  (Tran, et.al., 2017; Narayanasamy, et.al., 2019; Sciex, 2020). 
Presumptive analyte identification of untargeted analyses also depends on the analysis 
method used.  EPI mode requires analytes to have retention times and product ion spectra that 
match those of a database at an acceptable level.  Auto MS/MS mode and MSE mode require 
analytes to have retention times, precursor masses, isotope peak patterns, and product ion spectra 
that match those of a database at an acceptable level.  QTOF methods calculate the precursor 
mass and the isotope peak pattern, which, in combination with the right software, allows for the 
theoretical identification of all fragment spectra.  Agilent’s MassHunter software has an 
“Identify Metabolites” tool which uses an algorithm to find parent drugs or metabolites that may 
match the product ion spectra that did not have library matches.  Untargeted ion acquisition 
modes allow for retrospective data analysis, typically referred to as data mining; this is important 
because it allows for samples to be reassessed without requiring reanalysis on the instrument.  
(Broecker, et.al., 2011; Broecker, et.al., 2010; Bidny, et.al., 2016; Thoren, et.al., 2016; Colby, 
Thoren, & Lynch, 2018; Grapp, et.al., 2018). 
Margin of Error 
 The textbook description of margin of error, which is also referred to as measurement 
uncertainty or uncertainty, is a range in which the “true value” of a quantitative measurement is 
expected to fall.  It is not possible to measure the “true value” of an article; instead a method is 
developed that yields a measurement which is believed to be close to the “true value”.  Statistical 
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uncertainty is the level of confidence associated with that measurement.  The scientific purpose 
of reporting margin of error is to make the interpretation of results more meaningful by 
highlighting the confidence level of the reported result.  In the context of DUI/DUID cases, 
ethanol and drug concentrations are the articles being measured; the entire process used to make 
measurements contributes to the uncertainty of the values reported.  This process does not only 
include instrumental analysis, it also includes the human components of sample preparation and 
data analysis.  Interestingly, the human components of measurement processes contribute 
considerably more to the margin of error than the instrument(s) used as part of those 
measurement processes.  (Bell, 2016). 
Estimation of uncertainty is linked to the method development and method validation 
processes.  The process used for the estimation of uncertainty involves four key steps: 1) 
identification of potential uncertainty contributors, which often involves the use of a cause-and-
effect diagram and a review of the measurement procedure; 2) minimization of dispersion, which 
involves an evaluation of uncertainty contributors, and then attempts to reduce their uncertainty 
through optimization of the method; 3) quantification of uncertainty contributors, which involves 
the assignment of numerical values to contributors; and 4) estimation of uncertainty, which 
involves the use of an uncertainty budget.  Margin of error can be presented in the form of a 
percentage of the measurement, but is more commonly presented in the form of a range around 
the measurement.  (Bell, 2016). 
Traditionally, margin of error was a calculation reserved for the reporting of quantitative 
measurements.  More recently, margin of error is also being used to estimate the level of 
confidence for qualitative data.  For example, in the context of DUI/DUID cases, this could be 
the probability that the methamphetamine identified in a biological sample is in fact 
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methamphetamine, and not another drug, such as phentermine.  There are fewer available 
guidelines for qualitative uncertainty calculations, and the qualitative nature of the data reported 
increases the complexity of these calculations.  Bayes’ theorem of posterior odds is commonly 
being used for qualitative margin of error calculations, however, there is not a uniform method 
for the calculation of the prior odds and likelihood ratios that are used in this calculation.  
(Jackson, 2016; Marquis, et.al., 2017; Morrison, Ballentyne, & Geoghegan, 2018). 
The event that highlighted the importance of uncertainty measurements into the spotlight 
was the 2009 National Academy of Science Report (NAS Report), Strengthening Forensic 
Science in the United States: A Path Forward, which was written by several National Research 
Council committees.  The NAS Report recommended that, “Forensic reports, and any courtroom 
testimony stemming from them, must include clear characterizations of the limitations of the 
analyses, including measures of uncertainty in reported results and associated estimated 
probabilities where possible.”  The legal intent behind reporting margin of error is best 
summarized by Christensen, et.al., “if a method can be applied, error may exist and should be 
acknowledged.”  The denial of measurement uncertainty can lead to the misrepresentation of 
forensic results in a court of law.  However, the misunderstanding of measurement uncertainty 
by the court can also lead to a misrepresentation of forensic results.  This discussion is outside 
the scope of this review.  (National Research Council, 2009; Christensen, et.al., 2014). 
In the context of DUI/DUID analysis, the process used to perform a measurement is the 
largest contributor to uncertainty.  Consequently, there is not a meaningful way to compare the 
margin of error associated with each instrument included in this review, because margin of error 
must be calculated for each assay performed on each instrument in each lab.  And, while multiple 
labs may use the same instrumentation to perform a measurement, no unified process is used for 
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these measurements.  It is meaningful, however, to point out that as the number of steps in a 
measurement process increase, such as those used for sample preparation, so too will the 
potential uncertainty associated with that process increase.  (Bell, 2016). 
Cost 
 Information of costs of the laboratory instrumentation discussed herein is not readily 
available in published literature or on equipment manufacturer websites.  All instrument 
manufacturer websites have an option to “Request Quote” on each instrument page.  To gain an 
understanding of instrument cost, an attempt was made to contact a number of prominent 
instrument manufacturers; the procedure used for selecting manufacturers and contacting them is 
described in the “Methods” section.  Of the manufacturers contacted by customer service e-mail 
or website inquiry, only one response was received, and it was a redirect of the inquiry.  The 
redirect did not yield a response.  The two representatives who were contacted directly did 
respond to the inquiry, and their completed questionnaires can be found in Appendices D and E. 
 Shimadzu produces both gas chromatography and liquid chromatography instruments, 
with a variety of detection methods available.  As can be seen on the questionnaire, cost 
increases as the complexity of detection method increases; cost is lower for gas chromatography 
than liquid chromatography.  This is consistent with the review performed by Wu et.al., where 
GC/MS was described as being approximately ¼ the cost of LC/MS/MS.  It is important to note 
that the Wu et.al. study was the only one the author was able to find that listed approximate 
instrument pricing.  (Appendix D – Shimadzu Questionnaire Response; Wu et.al., 2012). 
 Sciex produces liquid chromatography instruments.  It offers multiple detection methods, 
and multiple models of each instrument.  Instead of filling out the questionnaire, Sciex 
representatives chose to have a conference call to discuss the complexity of the cost question.  
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Their questionnaire was filled out by the author using the information obtained during the 
conference call.  According to Sciex, a general estimation of cost is not quantifiable because the 
instrument and model selected depends on the needs of the lab.  The cost ranges associated with 
their instruments are quite wide, and generally overlap, thereby reducing the usefulness of inter-
instrument comparison.  Intra-instrument comparisons are possible, but again, depend on the 
needs of the lab.  The conclusion of this conversation was that cost is lab specific, and cannot be 
easily generalized.  (Appendix E – Sciex Questionnaire Response).  
Analytical Efficiency – Definition 
 Analytical efficiency is a term associated with both instrumentation/software efficiency, 
and whole laboratory efficiency.  Broadly speaking, analytical efficiency is the useful 
information obtained, weighed against the efforts required to obtain it; or more simply, analytical 
efficiency is the ratio of input to output.  According to a multiyear project sponsored by Agilent 
Technologies and executed by the Analytical Scientist, every lab has its own definition of 
analytical efficiency.  Additionally, there is not a one-size-fits-all definition for analytical 
efficiency; each lab must select the input and output parameters that are most important to it.  
(The Analytical Scientist, 2018, Your Efficiency Challenge – Part II; Agilent Technologies, 
2020). 
 The multiyear project sponsored by Agilent Technologies and executed by the Analytical 
Scientist began with a laboratory efficiency survey that was sent to over 1,200 liquid 
chromatography laboratories worldwide.  19% of the total laboratories surveyed were in North 
America, and 10% of the total laboratories surveyed were government organizations.  When 
asked about the “Importance of Various Topics with Regard to Liquid Phase Separations”, the 
top four answers were: 1) robustness of the entire analytical workflow, i.e. reliability of results; 
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2) low limits of detection; 3) quick turnaround time for our samples; 4) high sample throughput.  
It was noted that robustness of the workflow was considered to be especially important to 
government organizations, and that turnaround time was especially important to facilities in 
North America.  When asked about “Additional Major Challenges Regarding Efficiency and 
Liquid Separation Methods”, the top answers included: methods, applications; resolution, 
sensitivity; sample preparation; software, data analysis; and, speed. (The Analytical Scientist, 
2018, Laboratory Efficiency and Liquid Separations Survey Report). 
Analytical Efficiency – Evaluation Criteria 
The criteria that were ultimately selected for the analytical efficiency evaluation focused 
on robustness of the entire analytical workflow, which includes instrument set-up, sample 
preparation, instrument results, and data analysis.  The robustness evaluation included a review 
of the relevant Daubert Prongs as applied to each step of the analytical workflow, as well as a 
review of LOD and turnaround time.  The objective parameters the author used for the evaluation 
of the analytical efficiency of the instrumentation included those identified to be most important 
by both the government organizations and the North American laboratories surveyed; the 
parameters selected address the efficiency challenges described by the laboratories surveyed. 
Margin of error and cost were not included as criteria for the analytical efficiency 
evaluation, because specific information covering these topics is not readily available in the 
published literature.  Margin of error, like analytical efficiency, is lab and process specific.  
Thus, it was determined that an attempt to quantify margin of error in regard to analytical 
efficiency would not be meaningful.  However, non-instrument factors, such as sample 
preparation, that contribute to margin of error may be discussed.  Cost is also lab specific, in that 
each lab has different testing needs and a different budget.  Additionally, labs may already own 
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the instrumentation being discussed, but could be seeking ways to use that instrumentation more 
efficiently.  Thus, it was determined that cost would not be meaningful in regard to analytical 
efficiency. 
Analytical Efficiency – Instrument Evaluations 
An evaluation of the analytical efficiency of the instrumentation that was described above 
follows.  Each instrument was evaluated against the four specifications detailed (Robustness of 
Instrument Set-up, Robustness of Sample Preparation, Robustness of Instrument Results, and 
Robustness of Data Analysis).  In an attempt to quantify the analytical efficiency of each 
instrument, each specification was given a numerical value ranging from 1-5.  This value was 
derived from an evaluation of the applicable Daubert Prongs, the level of complexity and time 






Point Value General Assessment Criteria
1 Doesn't give desired results
2 Extremely complex and time consuming
3 Relatively higher level of complexity and ample time required
4 Moderate level of complexity and moderate time required
5 Lower level of complexity and minimal time required
Specification Specific Assessment Criteria
Robustness of Instrument Set-up
Pre-configured instrument available?  Develop method from 
scratch or modify exiting method from another instrument?
Robustness of Sample Preparation
Number of steps in sample preparation; as steps increase, so 
does potential for error.  Volume of sample required.
Robustness of Instrument Results Multiple tests required?
Robustness of Data Analysis Potential for erroneous results?
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HS-GC/FID – Presently-Applied Technique 
 HS-GC/FID has been the instrumentation of choice for the analysis of blood alcohol 
concentration for over 40 years; this has paved the way for its peer review and general 
acceptance by the relevant scientific community.  Blood alcohol testing is unique because it 
exploits the inherent chemical properties of the target analyte.  The extreme volatility of alcohol 
allows for the application of heat to move the alcohol out of the biological matrix and into the 
headspace where it can be sampled and analyzed.  The optimization of this process makes HS-
GC/FID very effective and efficient for the quantitation of blood alcohol concentration. 
LOD is not an issue for this method, because all states have predetermined limits for 
blood alcohol concentration, and the limits are fairly high when considered against the capability 
of most instruments.  Kaya et.al. reported an ethanol LOD as 0.00448 g/dL, which is more than 4 
times lower than 0.02 g/dL, the LOQ many states appear to use.  Turnaround time is not a key 
issue for this method, because the ease of the sample preparation process and the data analysis 
process make up for the somewhat longer run time.  (Kaya et.al., 2011; Nolo, n.d). 
Robustness of Instrument Set-up:  As described above, HS-GC/FID instruments can be 
purchased pre-configured, ready for the comprehensive validation procedure that is performed 
under controlled conditions to evaluate the test system for erroneous results.  Even when 
instruments are purchased that are not pre-configured, the familiarity that labs have with this 
method typically allows for easy method development.  The establishment of this method, and 
the ease of method development are why Robustness of Instrument Set-up is receiving a 5-point 
rating. 
 Robustness of Sample Preparation:  The sample preparation method used for this 
technique has also been well established, peer reviewed, and generally accepted.  There are very 
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few steps in the sample preparation process; in addition to making this a swift process, it also 
reduces the potential for error.  The simplicity of the sample preparation process is why 
Robustness of Sample Preparation is receiving a 5-point rating. 
 Robustness of Instrument Results:  Including sample incubation and actual instrument 
run time, a single sample typically takes less than 30 minutes to run.  Because these runs are for 
quantitative purposes, they require a full calibration curve and QCs in addition to case samples, 
which increases the total run time.  Depending upon whether the instrument is single or dual 
columned, one or two chromatograms are produced by the instrument.  The use of a second 
column allows for the qualitative identification of alcohol.  However, because the practice of 
forensic science is moving toward spectral confirmation for qualitative identification, some labs 
are required to prepare and run additional samples.  The need to run additional confirmation 
assays is why Robustness of Instrument Results is receiving a 4-point rating. 
 Robustness of Data Analysis:  When performed properly, data analysis is a fairly simple 
process of building a calibration curve, verifying that curve with QCs, and then quantitating case 
samples.  This process can be performed using manufacturer-provided software, though manual 
verification of results is required.  The simplicity of this process is why Robustness of Data 
Analysis is receiving a 5-point rating. 
HS-GC/FID/MS – Emerging Technique 
HS-GC/FID/MS is a valuable method because it sustains the strengths of HS-GC/FID, 
while tackling its primary weakness, the lack of spectral confirmation.  Peer review for this 
method comes in the form of articles detailing side by side comparisons that labs have executed 
as part of their validation of this method.  Tiscione et.al. re-analyzed 81 case samples as part of 
its evaluation of HS-GC/FID/MS; its results showed exceptional correlation with their 
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established HS-GC/FID method.  The primary advantage they cited for this method was the two-
in-one quantitation and spectral confirmation.  (Tiscione, et.al., 2011). 
Robustness of Instrument Set-up:  HS-GC/FID/MS is simply an upgraded version of a 
well-established, peer reviewed, generally accepted technique.  The general acceptance of this 
technique is evidenced by the instrument manufacturers who are already offering pre-configured 
instruments specifically marketed for forensic labs.  Even when instruments are purchased that 
are not pre-configured, the familiarity that labs have with both HS-GC/FID and GC/MS methods 
allows for easy method development.  This ease of method development is why Robustness of 
Instrument Set-up is receiving a 5-point rating. 
 Robustness of Sample Preparation:  The sample preparation method used for this 
technique is the same well established, peer reviewed, and generally accepted technique used for 
HS-GC/FID.  There are very few steps in the sample preparation process, which in addition to 
making it a swift process, also reduces the potential for error.  The simplicity of the sample 
preparation process is why Robustness of Sample Preparation is receiving a 5-point rating. 
 Robustness of Instrument Results:  Including sample incubation and actual instrument 
run time, a single sample typically take less than 30 minutes to run.  Because these runs are for 
quantitative purposes, they require a full calibration curve and QCs in addition to case samples, 
which increases the total run time.  HS-GC/FID/MS allows for the simultaneous analysis of both 
blood alcohol quantitation and spectral confirmation, which makes this method highly efficient, 
as it eliminates the need for additional analyses.  The dual functionality of quantitation and 
spectral confirmation is why Robustness of Instrument Results is receiving a 5-point rating. 
 Robustness of Data Analysis:  When performed properly, data analysis is a fairly simple 
two-step process.  The first step involves the construction of a calibration curve, the verification 
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of the curve with QCs, and then quantitation of case samples.  The second step involves 
searching for ethanol in a spectral library.  This process can be performed using manufacturer 
provided software, though manual verification of results is required.  The straightforwardness of 
this process is why Robustness of Data Analysis is receiving a 5-point rating. 
Traditional Immunoassays – Presently-Applied Techniques 
Immunoassays have been peer reviewed and generally accepted for decades, but it is 
important to remember that immunoassays are merely a screening tool.  Immunoassays are not 
generally analyte specific; instead they tend to target a drug class.  Additionally, they are known 
to produce erroneous results, even when performed under controlled conditions and using 
validated methods.  Immunoassay results cannot be the sole evidentiary test performed on a case 
sample because they do not satisfy all of the Daubert prongs.  However, immunoassays are a 
good compass for confirmation testing. 
Robustness of Instrument Set-up:  Immunoassays typically come in the form of semi- or 
fully-automated systems that have reagent kits which can be purchased for each assay; as a 
result, instrument set-up is fairly easy.  The lack of method development, paired with the ease of 
system set-up are why Robustness of Instrument Set-up is receiving a 5-point rating. 
 Robustness of Sample Preparation:  Immunoassays typically use unprocessed samples, or 
require simple dilution prior to analysis.  The lack of sample preparation required, is why 
Robustness of Sample Preparation is receiving a 5-point rating. 
 Robustness of Instrument Results:  Immunoassays are advertised as being quick and easy 
tests.  However, an issue that some labs encounter with traditional immunoassays, is the limited 
number of reagents that can be held in the reagent wheel of a semi-automated or fully-automated 
analytical system.  For example, an automated analytical system for immunoassays can hold the 
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reagents for 12 assays, but forensic labs often screen for more than 12 assays, so labs must often 
run the analytical system twice for every sample, which slows turnaround time.  Additionally, 
some immunoassays have long incubation periods, up to 60 minutes, which also slows 
turnaround time.  The inefficiency of running a system twice, and the potentially long incubation 
times for “quick and easy tests” are why Robustness of Instrument Results is receiving a 4-point 
rating. 
 Robustness of Data Analysis:  Immunoassay results come in the form of detected or not 
detected, however, the interpretation of these results is not as straightforward as it would seem 
because immunoassays are known to have erroneous results.  There can be false negatives if 
cutoffs are above the cutoff of the corresponding confirmation assay.  Or, false positives can be 
caused by cross-reacting substances.  While false negatives are a problem, false positives are a 
greater problem, as they may mis-direct the course of confirmation testing.  Not only does this 
hurt turnaround time, it also reduces the quantity of biological sample available for further 
testing.  The propensity for erroneous results is why Robustness of Data Analysis is receiving a 
3-point rating. 
Biochip Array Technology – Emerging Technique 
BAT is a method that has significant potential, because it uses the generally accepted 
technology of ELISA, and addresses some of its weaknesses.  The multiplexing ability of these 
assays makes them very attractive to labs that are currently limited by the number of reagent 
positions on their analyzers.  Perhaps the reason that BAT seems to be gaining general 
acceptance in forensic labs is because it is perceived as the next generation of immunoassays. 
Robustness of Instrument Set-up:  Like traditional immunoassays, BAT comes in the 
form of semi- or fully-automated systems; because of this, instrument set-up is fairly easy.  The 
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lack of method development, paired with the ease of system set-up are why Robustness of 
Instrument Set-up is receiving a 5-point rating. 
 Robustness of Sample Preparation:  BAT typically requires only simple dilution prior to 
analysis on fully-automated systems.  The lack of sample preparation required, is why 
Robustness of Sample Preparation is receiving a 5-point rating. 
Robustness of Instrument Results:  BAT is advertised as being quick, easy, and accurate.  
As mentioned previously, each biochip contains internal quality control DTRs.  If one or more of 
the internal quality control DTRs do not meet specifications, an error code is generated, and the 
sample will need to be reanalyzed.  (Randox Laboratories, 2014).  Additionally, some BAT 
assays have somewhat long incubation periods, up to 30 minutes, which slows the turnaround 
time.  The associated incubation time for “quick and easy tests”, and the potential to have to 
rerun samples due to faulty DTRs are why Robustness of Instrument Results is receiving a 4-
point rating. 
 Robustness of Data Analysis:  BAT biochips contain a scavenger antibody that seems to 
do a reasonably good job of preventing false positives.  However, studies have also shown that 
when the cutoffs of the assays are at the manufacturer recommended levels (5 ng/mL), the 
number of false positives increases.  The cutoff has to be raised to a therapeutically relevant level 
(25 ng/mL) to reduce false positives.  (Castaneto, et.al., 2015).  The possibility of erroneous 
results caused by manufacturer recommended test cutoffs being too low is why Robustness of 
Data Analysis is receiving a 4-point rating. 
GC/MS – Presently-Applied Technique 
 GC/MS has been a lab staple for half a century; it was the first technique that coupled 
chromatography with mass spectrometry, and it has been generally accepted and peer reviewed 
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for decades.  GC/MS is so engrained as the “gold standard” technique, that television shows and 
books even mention it by name when trying to make forensic science references.  It is likely the 
most widely known forensic analytical instrument.  Validated methods, performed under 
controlled conditions, have proven the lack of erroneous results.  GC/MS has the ability to detect 
concentrations in the ng/mL range, but first, analytes need to be compatible with the testing 
technology.  GC/MS is unique, in that many analytes must be forced into compatibility by 
derivatization, and even then, there are analytes that may not be compatible with GC/MS 
analysis. 
Robustness of Instrument Set-up:  As described above, GC/MS instruments can be 
purchased pre-configured, ready for the comprehensive validation procedure that is performed 
under controlled conditions and evaluates the test system for erroneous results.  Even when 
instruments are purchased that are not pre-configured, the familiarity that labs have with this 
method allows for easy method development.  The establishment of this method, and the ease of 
method development are why Robustness of Instrument Set-up is receiving a 5-point rating. 
 Robustness of Sample Preparation:  Sample preparation for GC/MS is a long, tedious 
process; in addition to extraction, derivatization is often also required.  Because GC/MS extracts 
need to be as clean as possible, sample preparation processes typically require multiple steps; 
subsequent derivatization can also be a multi-step process.  All the steps in the sample 
preparation process are sites for potential error.  If not performed properly, analytes may not 
derivatize properly, which will inhibit their detection.  Also, GC/MS sample preparation 
procedures may require a considerable quantity of sample, because the sample prep process is 
intended to concentrate the target analytes.  This reduces the quantity of sample available for 
other analyses.  The complicated sample preparation process, in combination with the 
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requirement for derivatization and sample concentration are why Robustness of Sample 
Preparation is receiving a 3-point rating. 
 Robustness of Instrument Results:  The long sample preparation procedure is usually 
followed by a long instrument run time (up to 60 minutes).  An advantage that GC/MS has is the 
ability to simultaneously run SIM and scan analyses when using FASST mode.  This ability to 
run simultaneous targeted and untargeted screens can prevent the need for future runs, however, 
not all instruments have this capability.  The long analysis time is why Robustness of Instrument 
Results is receiving a 4-point rating. 
 Robustness of Data Analysis:  The use of spectral libraries to identify unknown peaks 
dates back to the 1970s, when these libraries had to be accessed by telephone.  It is interesting to 
note that even back in the 1970s, analysts recognized the importance of both retention time and 
spectral library matches to confirm analytes, as well as manual verification of library matches.  
(Finkle, Foltz, & Taylor, 1974; Finkle, Taylor, & Bonelli, 1972).  The methods used for GC/MS 
analyte confirmation are generally accepted and peer reviewed.  The use of manufacturer 
provided software, and additional software, like AMDIS help speed the data analysis process.  
The well-established methodology for analyte confirmation is why Robustness of Data Analysis 
is receiving a 5-point rating. 
LC/MS/MS – Emerging Technique for Confirmatory Testing 
LC/MS/MS is a technique that has been embraced wholeheartedly by clinical 
toxicologists since the late 1990s.  According to Grebe & Singh, the reason for this acceptance is 
that “It [LC/MS/MS] seemed to offer all the advantages of GCMS without the disadvantages of 
compromised detection sensitivity and long chromatography run-times.”  (Grebe & Singh, 2011).  
According to Logan, et.al., LC/MS/MS is gaining traction in the forensic science community as 
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well.  (Logan, et.al., 2017).  However, LC/MS/MS has the stigma of being much more complex 
than GC/MS, which may discourage prospective users, and cause existing users to underutilize 
their instrumentation. 
LC/MS/MS has been extensively peer reviewed; in spite of this, it has not yet received 
the same level of general acceptance as GC/MS.  Many authors seem eager to point out the 
perceived weakness of LC/MS/MS in favor of the perceived strengths of GC/MS.  Other authors 
eagerly describe LC/MS/MS as the perfect complement to GC/MS; this is because LC/MS/MS is 
compatible with analytes that don’t work on GC/MS, or only work when forced.  LC/MS/MS has 
the ability to detect concentrations in the ng/mL range, sub ng/mL range, and some instruments 
can even detect concentrations as low as the pg/mL range.  (Sciex, n.d.)  Validated methods, 
performed under controlled conditions have demonstrated the lack of erroneous results. 
Before defining the analytical efficiency of LC/MS/MS, it is important to review the 
three common types that are being used.  LC/QQQ uses a targeted MRM scan to identify 
analytes; the results obtained from this assay are considered confirmatory.  LC/QLIT has the 
ability to analyze samples in MRM-EPI mode, which is a targeted scan used to identify analytes; 
it includes the use of a library search, the results of which are considered confirmatory.  
LC/QLIT also has the ability to perform a full scan of samples in EPI mode; this is an untargeted 
scan which is often considered to be a presumptive result.  LC/QTRAP also has the ability to 
perform an untargeted full scan, in auto MS/MS mode; it is also often considered to be a 
presumptive result.  The forensic science regulatory standards require that MS/MS assays have 
targeted diagnostic ions to be considered confirmatory.  (Standard for Identification Criteria in 
Forensic Toxicology; Academy Standards Board, n.d., Standard for Mass Spectral Data 
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Acceptance in Forensic Toxicology, n.d.).  For this reason, the analytical efficiency evaluation 
will only consider targeted analysis mode. 
Robustness of Instrument Set-up:  When LC/MS/MS is used in a targeted analysis mode, 
both the precursor and product ions must be known.  Collision parameters for the product ions of 
each precursor ion must be optimized.  There are resources available to aid this process, 
however, doing so requires more effort than any of the previous method development processes 
described.  LC/MS/MS is very customizable, which goes hand in hand with the increased level 
of complexity required to bring an instrument online.  The complexity and customizability of 
method development are why Robustness of Instrument Set-up is receiving a 4-point rating. 
 Robustness of Sample Preparation:  The complexity of sample preparation for 
LC/MS/MS is much lower than the level of complexity of GC/MS sample prep.  One of the 
reasons for this lower level of complexity is the absence of derivatization.  The volume of 
sample required for LC/MS/MS extractions is generally smaller than the volume required for 
GC/MS extractions because LC/MS/MS does not typically require a concentration step.  GC/MS 
also requires very clean samples; because of the increased sensitivity of LC/MS/MS, sample prep 
is required, but extracts do not have to be as clean as those necessary for GC/MS.  A sample 
extraction method Sciex recommends for blood is PPT.  This preparation method has the 
potential to cause matrix effects, but these can be ameliorated during the method development 
process by optimization of chromatography parameters and/or the utilization of stable-isotope 
ISs.  As discussed, the fewer steps there are in the sample preparation process, the fewer places 
there are for error to occur.  Additionally, LC/MS/MS has the unique ability to perform on-line 
sample extraction, which practically eliminates the sample preparation process, and drastically 
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reduces the potential for error.  The ease of the sample preparation process is why Robustness of 
Sample Preparation is receiving a 5-point rating. 
 Robustness of Instrument Results:  An advantage that LC/MS/MS has over GC/MS is its 
vastly reduced run time, typically less than 10 minutes.  LC/MS/MS employs a targeted analysis, 
whereby analytes are only detected if they are included in the method.  An advantage of targeted 
analysis is increased sensitivity for target analytes.  While the targeted analysis approach 
employed by LC/MS/MS has advantages, a disadvantage is that the data received is limited to 
the pre-selected target analytes.  The limitation of using a targeted analysis is why Robustness of 
Instrument Results is receiving a 4-point rating. 
 Robustness of Data Analysis:  LC/MS/MS data is processed using manufacturer provided 
software, however, its analysis process is not as automated as the analysis process used for 
GC/MS.  Peaks require manual verification, and may even require manual integration.  The 
development of data analysis parameters is a very important step of method development and 
validation.  The libraries available for use with LC/MS/MS are typically manufacturer specific; 
this is due to inter-instrument differences in CID fragmentation, which cause differences in the 
resulting product ion spectra.  Generally, if a library is going to be used, the CID parameters 
need to be similar to those of the library.  This limitation of the variability of libraries may be 
one reason why targeted analyses are required for confirmation.  Once factor contributing to the 
popularity of MRM mode may be its targeted identification of multiple product ions, whereby it 
does not have to rely on the use of potentially variable libraries.  The labor-intensive nature of 
data analysis is why Robustness of Data Analysis is receiving a 4-point rating. 
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LC/MS/MS – Emerging Technique for Presumptive Testing 
As mentioned earlier, LC/MS/MSs used in untargeted modes only qualify as presumptive 
tests; this is a limitation when considering these instruments for confirmatory testing.  However, 
its utility of untargeted scans for screening purposes is an advantage when comparing 
LC/MS/MS to immunoassay screening, as immunoassay screening is often limited to pre-
established drugs/drug classes.  When used for screening purposes, LC/MS/MS has the potential 
to presumptively identify novel, synthetic, and designer drugs that may not yet be widely known.  
These are drugs that would likely be missed by other methods for one of several reasons: they 
don’t cross react well enough in immunoassays; due to lack of compatibility or lack of a library 
entry, they may be missed by general untargeted GC/MS screens; and, because cutting edge 
drugs may not be included in the panel, they would be missed by targeted LC/MS/MS analyses.  
LC/MS/MS screening is a technique that has undergone substantial peer review; it is also gaining 
traction as a generally accepted method because of its advantages over immunoassay screening.  
These advantages are why the analytical efficiency of LC/MS/MS as a screening tool was 
evaluated. 
Robustness of Instrument Set-up:  When LC/MS/MS is used in an untargeted analysis 
mode, it does not require as extensive method development as when it is used in targeted 
analyses.  LC/MS/MS untargeted analyses require optimization of chromatography settings, 
optimization of scan criteria, and the selection of IDA parameters.  The method development 
required for an LC/MS/MS screen is much more complex than the relative simplicity of 
purchasing a ready-to-use immunoassay system; this is why Robustness of Instrument Set-up is 
receiving a 3-point rating. 
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 Robustness of Sample Preparation:  Because LC/MS/MS is a chromatography technique, 
sample preparation is required.  While the sample preparation required is generally less labor-
intensive than GC/MS sample preparation, it is considerably more labor-intensive than the 
minimal sample preparation required for immunoassays.  The requirement of sample preparation 
is why Robustness of Sample Preparation is receiving a 4-point rating. 
 Robustness of Instrument Results:  LC/MS/MS has several advantages over 
immunoassays, including shorter run time, specific analyte presumptive identification (versus a 
drug class), increased sensitivity, and the ability to run an untargeted scan.  An untargeted scan 
allows for presumptive identification of compounds that would be missed by immunoassays.  It 
also allows for the presumptive identification of novel, synthetic, or designer drugs that may not 
yet have reference standards, or may not yet be in analyte libraries; these limitations would cause 
them to be missed by targeted LC/MS/MS analyses and untargeted GC/MS analyses.  The 
presence of an analyte peak, even one that is unable to be identified, indicates the need for 
further analysis of the case sample, and could indicate a change in the drug habits of the 
geographic region.  The data-mining capabilities of untargeted screens allow for future reanalysis 
of screen results, such as the development of a reference standard or the development of a library 
spectrum for novel, synthetic, or designer drugs.  The advantage of employing an untargeted 
analysis is why Robustness of Instrument Results is receiving a 5-point rating. 
 Robustness of Data Analysis:  Immunoassay systems automatically produce results upon 
completion of the system’s analysis.  LC/MS/MS data must be manually processed to produce a 
result.  The process used for the analysis of untargeted data can be more labor-intensive than the 
one used for targeted data.  Presumptive identification of untargeted analytes is more dependent 
on data analysis than on data collection, which is why the establishment of data analysis 
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parameters is so important.  The requirement for data analysis, as well as the complex nature of 
data analysis, are why Robustness of Data Analysis is receiving a 4-point rating. 
Conclusion 
Each instrument was evaluated against the four analytical efficiency specifications 
detailed (Robustness of Instrument Set-up, Robustness of Sample Preparation, Robustness of 
Instrument Results, and Robustness of Data Analysis), and was assigned a numerical value 
ranging from 1-5, in an attempt to quantify their analytical efficiency.  The values for each 
instrument were then totaled, see Table 2 below. 
Table 2 
 
 This study showed that there is not a one-size-fits-all preferred instrument for the analysis 
of DUI/DUID case samples.  The variations in laboratory needs, capabilities, and definitions of 
analytical efficiency are why there is not a single best instrument.  These variations are observed 
in the responses of the previously-mentioned surveys by Logan, et.al. and The Analytical 
Scientist.  In the Logan, et.al. survey, some labs determined that the National Safety Council’s 
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laboratory, so they made no effort to be compliant with them.  (Logan, et.al., 2017).  In the 
Analytical Scientist’s survey, some labs stated their resistance to change, and/or they questioned 
whether the benefits of adding new analyses outweighed the disadvantage of losing an analyst 
for an unspecified period of time in order to bring a new instrument online.  (The Analytical 
Scientist, 2019, Your Efficiency Challenge – Part III). 
The available instruments not only compete with one another, but can also complement 
one another when used together for the analysis of DUI/DUID case samples.  While some of the 
emerging techniques appear to be more analytically efficient than presently-applied techniques, 
this does not discount the overall utility and analytical efficiency of the presently-applied 
techniques; the narrow spread of the analytical efficiency totals is evidence of this conclusion. 
 This study also showed that there is not a uniform definition of analytical efficiency; each 
lab must select the input and output parameters that are most important to them.  When labs are 
looking to purchase instruments, they need to assess and identify their testing needs, their 
budget, and their capability to bring a new instrument online.  Labs then need to partner with 
instrument manufacturers, who should help them select the right instrument for the task at hand.  
Instrument manufacturers may also be able to provide labs with resources to aid in method 
development.  The ACS’s Top Instrument Firms of 2018 also included a top 10 manufacturer 
ranking based on R&D spending.  Danaher, the parent company of Sciex, was ranked #1, 
followed by Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and Waters 
Corporation; Shimadzu Corporation did not make this list.  (Reisch, 2019). 
 It was observed that when emerging technology is merely an enhancement or upgrade of 
existing technology, as is the case with HS-GC/FID/MS and BAT, it tends to gain general 
acceptance faster than emerging technology which employs an entirely new technique, such as 
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LC/MS/MS.  Though LC/MS/MS is chromatography coupled to mass spectrometry, as is 
GC/MS, LC/MS/MS uses a different type of chromatography and a different type of mass 
spectrometry.  The study by Agilent and the Analytical Scientist found that some labs are 
reluctant to move away from legacy methods, even if newer methods could improve analytical 
efficiency.  The study also determined that labs view the time and effort necessary to improve 
current testing methods as a significant impediment.  (The Analytical Scientist, 2019, Your 
Efficiency Challenge – Part III).  The survey that was part of the Recommendations for 
Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities – 2017 
Update noted that the most common rationales given by labs for their lack of compliance with 
recommended standards were lack of staff, lack of time, and budget restrictions.  (Logan, et al., 
2017).  The lack of staff and lack of time issues can be compounded when a new instrument is 
introduced; because the primary function of forensic analysts is to perform casework, if they are 
required to develop and validate methods on a new instrument, then they are not doing casework, 
and a casework backlog can develop.  Labs that are resistant to change often do not have the 
manpower necessary to learn how to develop methods on a new instrument, or the budget to hire 
a consultant to set up a new instrument.  Instead, they may determine that purchasing a newer 
version of the instrument they need to replace is the most efficient option for their lab because of 
the ease with which they will be able to bring it online. 
 The previously-mentioned survey by Logan, et.al., listed instrument technology as a 
reason for lack of compliance with recommended guidelines, with 52% of labs working toward 
compliance with the standard.  LC/MS/MS may be a good option for those labs looking to 
improve their compliance by upgrading their instrument technology if they are willing to either 
put in the time and effort required for method development, or if they have the budget to hire a 
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consultant.  For labs looking to upgrade their instrument technology, but lack the time required 
for method development or the budget for a consultant, an option may be teaming up with local 
universities, farming method development out to graduate students.  The previously-mentioned 
2009 NAS Report states that educational programs should, “prepare the next generation of 
forensic practitioners” to better prepare forensic science students for casework.  (National 
Research Council, 2009).  Forensic labs farming out method development work to university 
students would benefit labs, as they would not have to sacrifice casework to bring a new 
instrument online.  This approach would benefit university students, as it would expose them to 
the particulars of forensic labs, while training them over instrumentation they will be using 
should they become forensic analysts.  This approach would subsequently aid forensic labs that 
hire these students; when the labs want to add additional tests to their instruments, their new 
hires will be familiar with the method development process, thereby enabling new tests to be 
added more efficiently. 
 While there does not appear to be a single best instrument for the analytical efficiency of 
all forensic labs, there are many instruments available from which to choose.  Ultimately, it is up 
to each individual lab to select the instrument(s) that best suit their unique analytical efficiency 
needs.  Hopefully, having a document that describes the similarities and differences among the 
capabilities of the available instruments will aid labs in their decision-making process.  General 
considerations that labs may want to take into account during their decision-making process 
include: 
 Labs currently using GC/MS that do not have analysts available to dedicate the time 
needed to develop methods on an LC/MS/MS, or the budget to hire a consultant, may be 
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best served by purchasing a newer version of GC/MS, because they will be able to bring 
it online more quickly. 
 Labs currently using GC/MS that have analysts available to dedicate the time needed to 
develop methods on an LC/MS/MS, or have the budget to hire a consultant, may want to 
consider getting an LC/MS/MS to take advantage of the benefits it offers. 
 Labs currently using HS-GC/FID, that are looking to boost the efficiency of their ethanol 
analyses, may want to consider a HS-GC/FID/MS, as it will allow them to combine two 
tests into one analysis. 
 Labs that are limited by the reagent handling capabilities of their immunoassay systems 
may want to consider multiplexing with BAT analysis. 
 Labs that are looking for screening systems with more sensitivity and increased analyte 
detection may want to consider LC/MS/MS untargeted screens. 
 Labs using their LC/MS/MS instruments for targeted confirmation analyses may want to 
consider adding untargeted screening analyses to them. 
 Labs using their LC/MS/MS instruments for untargeted screens may want to consider 
adding targeted confirmation analyses to them. 
 Labs that are in regions where new drugs are constantly being introduced may want to 
consider LC/MS/MS untargeted screens as a way to keep up with these changes and spot 
new drugs as they hit the streets. 
 Labs looking to lower their detection limits may want to consider LC/MS/MS. 
 Labs with limited funds available for instrument purchases may be best served by 
pursuing GC/MS and traditional immunoassay options. 
 




One limitation was the subjective nature used to write peer-reviewed literature.  Most of 
the available literature described each instrument reviewed as being well regarded for a series of 
traits including, but not limited to: sensitive, selective, having good resolution, accurate, precise, 
easy to use, and cost effective.  Attempts to find quantitative reports of these qualities for the 
purpose of inter-instrument comparison produced very little.  Even instrument manufacturers 
were not willing to share specifics on the capabilities of instrumentation.  When conversing with 
Sciex representatives, the author was informed that much of the information requested in the 
questionnaire sent to them was confidential. 
Another limitation was the lack of a uniform definition of both analytical efficiency and 
margin of error.  It is quite difficult to perform an objective analysis when the topic being 
analyzed has a subjective and fluid definition.  This was also complicated by the fact that every 
lab is different and has different needs/capabilities.  The previously-mentioned survey by Logan, 
et.al., also listed lack of relevance as a reason for lack of compliance with recommended 
guidelines.  Labs determined that the recommendations were not relevant because they may not 
encounter some of the analytes, or they encounter them at low rates.  (Logan, et.al., 2017).  This 
is an excellent example of the lack of uniformity of forensic analyses, which contributes to the 
complexity of making overarching recommendations. 
The final limitation is that this review was performed from an outsider’s perspective.  
Though the author has a background in clinical toxicology and laboratory accreditation as it 
pertains to medical laboratory testing, there are stark differences between clinical and forensic 
toxicology.  This review could have been more relevant if it was written by a practicing forensic 
Analysis of Forensic Laboratory Instrumentation Used for DUI/DUID Cases 
Pg. 92 
 
toxicologist who better understands forensic laboratory testing needs and the corresponding 
regulatory requirements. 
Future Research 
 One opportunity for future research includes in-lab comparisons of the different types of 
instrumentation described.  Lynch, et.al. did a comparison of vendor-supplied methods for five 
different instruments, and used it as an inter-instrument comparison.  Major limitations of this 
study were the lack of uniformity of sample preparation methods, and the analytes that each 
instrument was set up to detect.  Another limitation was the use of patient samples for the inter-
instrument comparison; it is unknown what drugs might have been in these samples, so 
reliability determinations are suspect, because perceived false positives could be drugs that were 
not tested for or identified by the original testing procedures.  (Lynch, et.al., 2010).  A more on-
point inter-instrument study would involve more uniform sample preparation methods, a defined 
panel of target analytes that is fully validated on all instruments involved in the study, and the 
use of known samples.  These known samples would be made using a blank matrix, and spiking 
it with known concentrations of the different drugs being analyzed; preferably, it would include 
multiple samples for target analytes at varying concentrations, to test across the linear ranges of 










Appendix A – Instrument Manufacturer Analysis 
 
 












Analysis of Forensic Laboratory Instrumentation Used for DUI/DUID Cases 
Pg. 96 
 
Appendix B – Instrument Manufacturer Cover Letter 
Hello Sir or Madam, 
 
I am a graduate student at the University of Central Oklahoma, pursuing a Master’s Degree in 
Forensic Chemistry.  My thesis project is a review covering the Analysis of Forensic Laboratory 
Instrumentation Used for DUI/DUID Cases.  I am performing an evaluation of presently-applied 
analytical techniques, as well as emerging techniques, with a goal of identifying the technique(s) 
with the highest analytical efficiency. 
 
Because part of my analysis includes an evaluation of instrumentation options, I am requesting 
that you have a member on your staff fill out the attached questionnaire with information 
regarding the capabilities and cost ranges of the instrument(s) your company offers for the 
forensic analysis of blood.  The instruments I am interested in are:  GC/MS, Headspace GC/FID, 
Headspace GC/FID/MS, LC/MS/MS, and LC/QTOF/MS. 
 
I realize that the capabilities of an instrument have a somewhat direct relationship with its cost.  
I’m trying to understand the advantages or disadvantages of purchasing the least and most 
expensive instruments.  I recognize that instrument costs are not published on your website for 
confidentiality reasons, which is why I am simply requesting that you list the instrumentation 
you offer in order by cost, from low to high.  But if possible, can you give me common price 
ranges? 
 
If you do not have time to fill out my questionnaire, I would appreciate it if you could send me a 
list of the instruments you have available for forensic toxicology applications, as well as any 
literature that may detail the differences between the instruments. 
 
If possible, I would like to request this information by July 1st. 
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Appendix C – Instrument Manufacturer Questionnaire 
 
Information requested:  Instrument Model(s) in order of cost, low to high; Forensic Specific 
Model; Pre-configured Assays; Comes with Analyte Library/Database; Resources Available to 
Aid Method Development; Compatible Software; Length of Time Required for Instrument Set-
up; Sensitivity - Common LODs and LOQs; Specificity – Resolution; Complexity of Instrument 
Maintenance; Margin of Error - for Forensic Reporting; Polarity switching capabilities; Other 
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Appendix D – Shimadzu Questionnaire Response 
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